

    <!DOCTYPE html>
<html class="">

        
<head>
    <title>Recent advances in the management of... | F1000Research</title>
    <meta charset="utf-8">
    <!--<meta http-equiv="Content-Type" content="text/html; charset=utf-8"/>-->
    <!--<meta lang="$locale">-->
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta name="google-site-verification" content="9-QVycOO2_ob3Z9QzRmXv2CF08A9oyYXqWyTiVdKPlU" />
    <!-- This is commented out to fix display problems on mobile devices.
    We may use it again once we implement a responsive design that supports native device resolutions.
    <meta name="viewport" content="width=device-width"> -->

    <meta name="viewport" content="width=device-width, initial-scale=1, maximum-scale=1">



    <link rel="alternate" title="Recent articles published in F1000Research" href="/rss" type="application/rss+xml">
            <link rel="alternate" type="application/pdf" title="PDF" href="https://f1000research.com/articles/7-758/pdf"/>
        <link rel="canonical" href="https://f1000research.com/articles/7-758" />
    
            <meta name="description" content="Read the original article in full on F1000Research: Recent advances in the management of lymphangioleiomyomatosis" />
    
            <meta name="og:title" content="F1000Research Article: Recent advances in the management of lymphangioleiomyomatosis.">
            <meta name="og:description" content="Read the latest article version by Kai-Feng Xu, Xinlun Tian, Jay H Ryu, at F1000Research.">
            <meta name="og:image" content="/img/sharing/og_research.png">
            <meta name="version-id" content="15851">
            <meta name="article-id" content="14564">
            <meta name="dc.title" content="Recent advances in the management of lymphangioleiomyomatosis">
            <meta name="dc.description" content="Lymphangioleiomyomatosis is a rare disorder that predominantly affects women and is characterized by progressive cystic changes in the lung, leading to gradually worsening shortness of breath and lung function impairment. Pleural complications such as pneumothorax and chylothorax commonly occur in these patients. Lymphangioleiomyomatosis can occur as a form of lung involvement in tuberous sclerosis complex or as a sporadic form (without tuberous sclerosis complex). Etiology in both forms of this disease centers on mutations in the tuberous sclerosis genes. Advances in our understanding of the regulatory role of tuberous sclerosis gene products (hamartin/tuberin) in the mechanistic target of rapamycin (mTOR) signaling pathway have led to the identification of effective therapy (mTOR inhibitors) for a rare disorder, once considered uniformly fatal. Here, we summarize the evolution of current concepts regarding lymphangioleiomyomatosis with an emphasis on recent advances and unresolved issues.">
            <meta name="dc.subject" content="Angiomyolipoma, Chylothorax, Lung transplantation, Lymphangioleiomyomatosis, Pneumothorax, Pulmonary rehabilitation, Rapamycin, Sirolimus, Tuberous sclerosis complex ">
            <meta name="dc.creator" content="Xu, Kai-Feng">
            <meta name="dc.creator" content="Tian, Xinlun">
            <meta name="dc.creator" content="Ryu, Jay H">
            <meta name="dc.date" content="2018/06/18">
            <meta name="dc.identifier" content="doi:10.12688/f1000research.14564.1">
            <meta name="dc.source" content="F1000Research 2018 7:758">
            <meta name="dc.format" content="text/html">
            <meta name="dc.language" content="en">
            <meta name="dc.publisher" content="F1000 Research Limited">
            <meta name="dc.rights" content="https://creativecommons.org/licenses/by/3.0/igo/">
            <meta name="dc.type" content="text">
            <meta name="prism.keyword" content="Angiomyolipoma">
            <meta name="prism.keyword" content="Chylothorax">
            <meta name="prism.keyword" content="Lung transplantation">
            <meta name="prism.keyword" content="Lymphangioleiomyomatosis">
            <meta name="prism.keyword" content="Pneumothorax">
            <meta name="prism.keyword" content="Pulmonary rehabilitation">
            <meta name="prism.keyword" content="Rapamycin">
            <meta name="prism.keyword" content="Sirolimus">
            <meta name="prism.keyword" content="Tuberous sclerosis complex ">
            <meta name="prism.publication.Name" content="F1000Research">
            <meta name="prism.publicationDate" content="2018/06/18">
            <meta name="prism.volume" content="7">
            <meta name="prism.number" content="758">
            <meta name="prism.versionIdentifier" content="1">
            <meta name="prism.doi" content="10.12688/f1000research.14564.1">
            <meta name="prism.url" content="https://f1000research.com/articles/7-758">
            <meta name="citation_title" content="Recent advances in the management of lymphangioleiomyomatosis">
            <meta name="citation_abstract" content="Lymphangioleiomyomatosis is a rare disorder that predominantly affects women and is characterized by progressive cystic changes in the lung, leading to gradually worsening shortness of breath and lung function impairment. Pleural complications such as pneumothorax and chylothorax commonly occur in these patients. Lymphangioleiomyomatosis can occur as a form of lung involvement in tuberous sclerosis complex or as a sporadic form (without tuberous sclerosis complex). Etiology in both forms of this disease centers on mutations in the tuberous sclerosis genes. Advances in our understanding of the regulatory role of tuberous sclerosis gene products (hamartin/tuberin) in the mechanistic target of rapamycin (mTOR) signaling pathway have led to the identification of effective therapy (mTOR inhibitors) for a rare disorder, once considered uniformly fatal. Here, we summarize the evolution of current concepts regarding lymphangioleiomyomatosis with an emphasis on recent advances and unresolved issues.">
            <meta name="citation_description" content="Lymphangioleiomyomatosis is a rare disorder that predominantly affects women and is characterized by progressive cystic changes in the lung, leading to gradually worsening shortness of breath and lung function impairment. Pleural complications such as pneumothorax and chylothorax commonly occur in these patients. Lymphangioleiomyomatosis can occur as a form of lung involvement in tuberous sclerosis complex or as a sporadic form (without tuberous sclerosis complex). Etiology in both forms of this disease centers on mutations in the tuberous sclerosis genes. Advances in our understanding of the regulatory role of tuberous sclerosis gene products (hamartin/tuberin) in the mechanistic target of rapamycin (mTOR) signaling pathway have led to the identification of effective therapy (mTOR inhibitors) for a rare disorder, once considered uniformly fatal. Here, we summarize the evolution of current concepts regarding lymphangioleiomyomatosis with an emphasis on recent advances and unresolved issues.">
            <meta name="citation_keywords" content="Angiomyolipoma, Chylothorax, Lung transplantation, Lymphangioleiomyomatosis, Pneumothorax, Pulmonary rehabilitation, Rapamycin, Sirolimus, Tuberous sclerosis complex ">
            <meta name="citation_journal_title" content="F1000Research">
            <meta name="citation_author" content="Kai-Feng Xu">
            <meta name="citation_author_institution" content="Department of Respiratory Medicine, Peking Union Medical College Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing , China">
            <meta name="citation_author" content="Xinlun Tian">
            <meta name="citation_author_institution" content="Department of Respiratory Medicine, Peking Union Medical College Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing , China">
            <meta name="citation_author" content="Jay H Ryu">
            <meta name="citation_author_institution" content="Division of Pulmonary and Critical Care Medicine, Mayo Clinic , Rochester, MN, USA">
            <meta name="citation_publication_date" content="2018/06/18">
            <meta name="citation_volume" content="7">
            <meta name="citation_publication_number" content="758">
            <meta name="citation_version_number" content="1">
            <meta name="citation_doi" content="10.12688/f1000research.14564.1">
            <meta name="citation_firstpage" content="758">
            <meta name="citation_pdf_url" content="https://f1000research.com/articles/7-758/v1/pdf">
    

    
    <link href="/img/favicon-research.ico" rel="shortcut icon" type="image/ico">
    <link href="/img/favicon-research.ico" rel="icon" type="image/ico">

        <link rel="stylesheet" href="/1597255280893/css/mdl/material-design-lite.css" type="text/css" media="all" />
    <link href="https://fonts.googleapis.com/icon?family=Material+Icons" rel="stylesheet">
    <link href="https://fonts.googleapis.com/css?family=Roboto:100,100i,300,300i,400,400i,500,500i,700,700i,900,900i" rel="stylesheet">
    <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/MaterialDesign-Webfont/2.2.43/css/materialdesignicons.min.css" />

        
            
    <link rel="stylesheet" href="/1597255280893/css/F1000Research.css" type="text/css" media="all" />
    <link rel="stylesheet" href="/css/F1000ResearchFontIcons/F1000ResearchFontIcons.css" type="text/css" media="all" />
    <link rel="stylesheet" href="/css/F1000ResearchFontIcons/animation.css" type="text/css" media="all" />

        <!--[if IE 7]><link rel="stylesheet" href="/css/F1000ResearchFontIcons/F1000ResearchFontIcons-ie7.css" media="all" /><![endif]-->

                    <script>dataLayer = [];</script>
        <!-- Google Tag Manager -->
        <script>(function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start':
        new Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0],
        j=d.createElement(s),dl=l!='dataLayer'?'&l='+l:'';j.async=true;j.src=
        'https://www.googletagmanager.com/gtm.js?id='+i+dl;f.parentNode.insertBefore(j,f);
        })(window,document,'script','dataLayer','GTM-54Z2SBK');</script>
        <!-- End Google Tag Manager -->
    
    <script src="https://ajax.googleapis.com/ajax/libs/jquery/1.8.1/jquery.min.js"></script>
    <script>window.jQuery || document.write('<script src="/js/vendor/jquery-1.8.1.min.js"><\/script>')</script>
    <script src="/1597255280893/js/vendor/modernizr-2.6.1-respond-1.1.0.min.js"></script>
    <script src="/1597255280893/js/shared_scripts/sticky.js"></script>
    <script src="/1597255280893/js/shared_scripts/helpers.js"></script>
    <script src="/1597255280893/js/shared_scripts/menu.js"></script>
    <script src="/1597255280893/js/shared_scripts/navbar.js"></script>
    <script src="/1597255280893/js/shared_scripts/platforms.js"></script>
    <script src="/1597255280893/js/shared_scripts/object-polyfills.js"></script>
            <script src="/1597255280893/js/vendor/lodash.min.js"></script>
        <script>CKEDITOR_BASEPATH='https://f1000research.com/js/ckeditor/'</script>
    <script src="https://f1000researchdata.s3-eu-west-1.amazonaws.com/js/plugins.js"></script>
    <script src="/1597255280893/js/shared_scripts/helpers.js"></script>
    <script src="/1597255280893/js/app/research.js"></script>
    <script>window.reactTheme = 'research';</script>
    <script src="/1597255280893/js/public/bundle.js"></script>

    <script src="/1597255280893/js/app/research.ui.js"></script>
    <script src="/1597255280893/js/app/login.js"></script>
    <script src="/1597255280893/js/app/main.js"></script>
    <script src="/1597255280893/js/app/js-date-format.min.js"></script>
    <script src="/1597255280893/js/app/search.js"></script>
    <script src="/1597255280893/js/app/cookies_warning.js"></script>
    <script src="/1597255280893/js/mdl/mdl.min.js"></script>

    <script src="https://cdnjs.cloudflare.com/ajax/libs/mathjax/2.7.1/MathJax.js?config=TeX-AMS-MML_HTMLorMML"></script>
                <script src="https://f1000researchdata.s3-eu-west-1.amazonaws.com/js/ckeditor.js"></script>
            <script src="/js/ckeditor/adapters/jquery.js"></script>
                <script src="/js/article/article_scrolling_module.js"></script>
            <script src="/js/article/article_stats.js"></script>
            <script src="/js/article/article.js"></script>
            <script src="/js/shared_scripts/referee_timeline_pagination.js"></script>
            <script src="/js/app/text_editor_controller.js"></script>
            <script src="//s7.addthis.com/js/250/addthis_widget.js#pubid=ra-503e5e99593dc42c"></script>
            <script src="/js/article/article_metrics.js"></script>
        
                                                                            <script>
            if (window.location.hash == '#_=_'){
                window.location = window.location.href.split('#')[0]
            }
        </script>

                    
        
    <!-- pixelId: 1641728616063202 :: assetPixelId: 6034867600215 :: funderPixelId:  -->

            <!-- Facebook pixel code (merged with EP GTM code) -->
        <script>
            !function(f,b,e,v,n,t,s){if(f.fbq)return;n=f.fbq=function()

            {n.callMethod? n.callMethod.apply(n,arguments):n.queue.push(arguments)}
            ;if(!f._fbq)f._fbq=n;
            n.push=n;n.loaded=!0;n.version='2.0';n.queue=[];t=b.createElement(e);t.async=!0;
            t.src=v;s=b.getElementsByTagName(e)[0];s.parentNode.insertBefore(t,s)}(window,
            document,'script','https://connect.facebook.net/en_US/fbevents.js');

            fbq('init', '1641728616063202');

            
            fbq('track', "PixelInitialized", {});
        </script>

        <noscript><img height="1" width="1" style="display:none"
            src="https://www.facebook.com/tr?id=1641728616063202&noscript=1&amp;ev=PixelInitialized"
        /></noscript>
        <!-- End Facebook Pixel Code -->
    
                <script>
            (function(h,o,t,j,a,r){
                h.hj=h.hj||function(){(h.hj.q=h.hj.q||[]).push(arguments)};
                h._hjSettings={hjid:917825,hjsv:6};
                a=o.getElementsByTagName('head')[0];
                r=o.createElement('script');r.async=1;
                r.src=t+h._hjSettings.hjid+j+h._hjSettings.hjsv;
                a.appendChild(r);
            })(window,document,'https://static.hotjar.com/c/hotjar-','.js?sv=');
        </script>
    
</head>
<body  class="o-page-container no-js p-article o-layout-reset   ">

    
                            <!-- Google Tag Manager (noscript) -->
        <noscript><iframe src="https://www.googletagmanager.com/ns.html?id=GTM-54Z2SBK"
        height="0" width="0" style="display:none;visibility:hidden"></iframe></noscript>
        <!-- End Google Tag Manager (noscript) -->
    
        
    <div class="o-page">

        <div id="notify-container"></div>
        <div id="pageWarning"></div>
        <div id="pageMessage"></div>
        <div id="pageFooterMessage"></div>

                                <div id="f1r-ga-data" data-name="f1r-ga-data" class="f1r-ga-data"
                data-user-registered="false"
                data-user-module=""
                data-current-path=""
                data-location=""
                data-website="F1000Research"
                data-websiteDisplayName="F1000Research">
            </div>
        
                
        
        <div class="header-wrapper   js-navbar-space ">
                            


    










        
                            
    
            



<nav class="c-navbar js-navbar js-mini-nav js-sticky c-navbar--js-sticky c-navbar--userSite c-navbar__platform-bgcolor  c-navbar--bg-f1000research ">

    <div class="c-navbar__content">

                                <div class="c-navbar__extras">
            <div class="o-wrapper">
                <div class="o-actions o-actions--middle c-navbar__extras-row">
                    <div class="o-actions__primary">
                        
                                            </div>
                                    </div>
            </div>
        </div>

        <div class="o-wrapper t-inverted js-sticky-start">

            <div class="c-navbar__branding-row">
                <div class="c-navbar__row">


                                        
                    <div class="c-navbar__primary u-mr--2">

                                                                                                                                                                                                    <a href="/" class="c-navbar__branding u-ib u-middle"   data-test-id="nav_branding"  >
                                <img class="u-ib u-middle" src="/img/research/F1000Research_white_solid.svg" alt="F1000Research">
                            </a>
                                            </div>

                    <div class="c-navbar__secondary c-navbar__row">


                                                
                                                    <form action="/search" class="-navbar__secondary u-mr--2 c-search-form js-search-form u-hide u-show@navbar">
                                <label for="searchInput" class="c-search-form__label _mdl-layout">
                                    <input name="q" type="search" class="c-search-form__input" id="searchInput" placeholder="Search">
                                    <button type="submit" class="c-search-form__submit mdl-button mdl-js-button mdl-button--icon"><i class="material-icons">search</i></button>
                                </label>
                            </form>
                        
                                                
                                                    <div class="c-navbar__primary u-hide u-show@navbar">
                                <div class="_mdl-layout c-navbar__cta">
                                    <a class="mdl-button mdl-js-button mdl-button--raised mdl-button--no-shadow mdl-button--multi-line mdl-js-ripple-effect mdl-button--inverted c-navbar__submit" href="/for-authors/publish-your-research"   data-test-id="nav_submit_research"  ><i class="material-icons">file_upload</i>Submit your research</a>
                                </div>
                            </div>
                        

                                                
                        <span class="u-hide@navbar _mdl-layout u-nowrap">

                                                            <button type="button" class="mdl-button mdl-js-button mdl-js-ripple-effect mdl-button--icon c-navbar__toggle c-navbar__toggle--menu js-navbar-toggle" data-focus="#navbar_mob_search_input" data-toggle="navbarMenu" data-target="navbarMenu" aria-controls="navbarMenu" aria-expanded="false" aria-label="Toggle navigation"   data-test-id="nav_menu_search_mob"  ><i class="material-icons">search</i></button>
                            
                                                            <button class="mdl-button mdl-js-button mdl-js-ripple-effect mdl-button--icon mdl-button--multi-line c-navbar__toggle c-navbar__toggle--menu js-navbar-toggle" type="button" data-toggle="navbarMenu" data-target="navbarMenu" aria-controls="navbarMenu" aria-expanded="false" aria-label="Toggle navigation"   data-test-id="nav_menu_toggle_mob"  >
                                    <i class="material-icons c-navbar__toggle-open">menu</i>
                                    <i class="material-icons c-navbar__toggle-close">close</i>
                                </button>
                                                    </span>
                    </div>

                </div>
            </div>

                        
                            <div class="c-navbar__menu-row js-navbar-block is-collapsed" id="navbarMenu">

                                                                                                                                                
                                                                    
                                                                    
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        
                                            

                                                                
                                                                                                                                                                                                                                
                                            
                    <div class="c-navbar__menu-row-content">

                                                                            <div class="u-hide@navbar c-navbar__menu-bar-spacing">
                                <form action="/search" class="c-search-form js-search-form">
                                    <label for="navbar_mob_search_input" class="c-search-form__label _mdl-layout">
                                        <input id="navbar_mob_search_input" name="q" type="search" class="c-search-form__input" placeholder="Search">
                                        <button type="submit" class="c-search-form__submit mdl-button mdl-js-button mdl-button--icon"><i class="material-icons">search</i></button>
                                    </label>
                                </form>
                            </div>
                        
                        <div class="o-actions o-actions--middle">

                            <div class="o-actions__primary">

                                                                
    <ul class="c-menubar c-navbar__menu-bar js-main-menu"   id="main-menu"   role="menubar" aria-label="Main Navigation"  data-menu-group="navbar" >

        
            
                                                                
                                
                                
                                    <li role="none"
                        data-index="0"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="/browse/articles" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                                                    tabindex="0"
                              data-test-id="nav_browse"                              >Browse</a>

                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="1"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="/gateways" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                                                    tabindex="-1"
                              data-test-id="nav_gatewaysViewAndBrowse"                              >Gateways & Collections</a>

                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="2"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                               c-menubar__item--selected c-navbar__menu-bar-item--parent ">

                        <a href="#" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                         aria-haspopup="true" aria-expanded="false"                             tabindex="-1"
                              data-test-id="nav_for-authors"                              >How to Publish</a>

                                                    
    <ul class="c-menu js-menu
                is-collapsed                c-menubar__menu c-navbar__menu"
                  role="menu"
        aria-label="How to Publish">

        
            
                                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_submit-manuscript"                      href="/for-authors/publish-your-research"
                    role="menuitem"
                    tabindex="0">Submit your Research</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-submissions"                      href="/for-authors/my-submissions"
                    role="menuitem"
                    tabindex="-1">My Submissions</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_article-guidelines"                      href="/for-authors/article-guidelines"
                    role="menuitem"
                    tabindex="-1">Article Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_article-guidelines-new-versions"                      href="/for-authors/article-guidelines-new-versions"
                    role="menuitem"
                    tabindex="-1">Article Guidelines (New Versions)</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_data-guidelines"                      href="/for-authors/data-guidelines"
                    role="menuitem"
                    tabindex="-1">Data Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_asset-guidelines"                      href="/for-authors/posters-and-slides-guidelines"
                    role="menuitem"
                    tabindex="-1">Posters and Slides Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_document-guidelines"                      href="/for-authors/document-guidelines"
                    role="menuitem"
                    tabindex="-1">Document Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_article-processing-charges"                      href="/for-authors/article-processing-charges"
                    role="menuitem"
                    tabindex="-1">Article Processing Charges</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_finding-referees"                      href="/for-authors/tips-for-finding-referees"
                    role="menuitem"
                    tabindex="-1">Finding Article Reviewers</a>

                </li>

                        </ul>
                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="3"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                               c-menubar__item--selected c-navbar__menu-bar-item--parent ">

                        <a href="#" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                         aria-haspopup="true" aria-expanded="false"                             tabindex="-1"
                              data-test-id="nav_about-contact"                              >About</a>

                                                    
    <ul class="c-menu js-menu
                is-collapsed                c-menubar__menu c-navbar__menu"
                  role="menu"
        aria-label="About">

        
            
                                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_about-page"                      href="/about"
                    role="menuitem"
                    tabindex="0">How it Works</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_referee-guidelines"                      href="/for-referees/guidelines"
                    role="menuitem"
                    tabindex="-1">For Reviewers</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_advisoryPanel"                      href="/advisors"
                    role="menuitem"
                    tabindex="-1">Our Advisors</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_policy-page"                      href="/about/policies"
                    role="menuitem"
                    tabindex="-1">Policies</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_glossary-page"                      href="/glossary"
                    role="menuitem"
                    tabindex="-1">Glossary</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_faqs-page"                      href="/faqs"
                    role="menuitem"
                    tabindex="-1">FAQs</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              u-hide u-show@navbar"
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      u-hide u-show@navbar"
                                          data-test-id="nav_for-developers"                      href="/developers"
                    role="menuitem"
                    tabindex="-1">For Developers</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_newsroom-page"                      href="/newsroom"
                    role="menuitem"
                    tabindex="-1">Newsroom</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_contact-page"                      href="/contact"
                    role="menuitem"
                    tabindex="-1">Contact</a>

                </li>

                        </ul>
                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="4"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="https://blog.f1000.com/blogs/f1000research/" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                             target="_blank"                                                         tabindex="-1"
                              data-test-id="nav_blog"                              >Blog</a>

                                            </li>
                
            
        
    </ul>



                            </div>

                            <div class="o-actions__secondary">

                                                                
    <ul class="c-menubar c-navbar__menu-bar js-main-menu"   id="secondary-items"   role="menubar" aria-label="My Account"  data-menu-group="navbar" >

        
            
                                                                
                                
                                
                                    <li role="none"
                        data-index="0"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                               c-menubar__item--selected c-navbar__menu-bar-item--parent ">

                        <a href="#" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                         aria-haspopup="true" aria-expanded="false"                             tabindex="0"
                              data-test-id="nav_my-research"                              >My Research</a>

                                                    
    <ul class="c-menu js-menu
                is-collapsed                c-menubar__menu c-navbar__menu"
                  role="menu"
        aria-label="My Research">

        
            
                                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-submissions"                      href="/login?originalPath=/my/submissions"
                    role="menuitem"
                    tabindex="0">Submissions</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-email-alerts"                      href="/login?originalPath=/my/email-alerts"
                    role="menuitem"
                    tabindex="-1">Content and Tracking Alerts</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-user-details"                      href="/login?originalPath=/my/user-details"
                    role="menuitem"
                    tabindex="-1">My Details</a>

                </li>

                        </ul>
                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="1"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="/login?originalPath=/articles/7-758.html" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                                                    tabindex="-1"
                              data-test-id="nav_sign-in"                              >Sign In</a>

                                            </li>
                
            
        
    </ul>



                            </div>

                                                                                        <div class="_mdl-layout c-navbar__cta u-hide@navbar c-navbar__menu-bar-spacing">
                                    <a class="mdl-button mdl-js-button mdl-button--raised mdl-button--multi-line mdl-button--no-shadow mdl-js-ripple-effect mdl-button--inverted c-navbar__submit" href="/for-authors/publish-your-research"   data-test-id="nav_submit_research_mob"  ><i class="material-icons">file_upload</i>Submit your research</a>
                                </div>
                                                    </div>

                    </div>

                </div>
            
        </div>

    </div>

</nav>
                    </div>

        <div class="content-wrapper o-page__main row ">
            <div id="highlight-area" class="content ">
                





<div id=article-metadata class=hidden> <input type=hidden name=versionId value=15851 /> <input type=hidden id=articleId name=articleId value=14564 /> <input type=hidden id=xmlUrl value="/articles/7-758/v1/xml"/> <input type=hidden id=xmlFileName value="-7-758-v1.xml"> <input type=hidden id=article_uuid value=ad2279cf-8dd6-4a13-b7e7-f948f36c01ec /> <input type=hidden id=referer value=""/> <input type=hidden id=meta-article-title value="Recent advances in the management of lymphangioleiomyomatosis"/> <input type=hidden id=workspace-export-url value="https://sciwheel.com/work/api/import/external?doi=10.12688/f1000research.14564.1"/> <input type=hidden id=versionDoi value="10.12688/f1000research.14564.1"/> <input type=hidden id=usePmcStats value=true /> </div> <main class="o-wrapper p-article__wrapper js-wrapper"> <script type="application/ld+json">
{
  "@context": "https://schema.org",
  "@type": "ScholarlyArticle",
  "mainEntityOfPage": {
    "@type": "WebPage",
    "@id": "https://f1000research.com/articles/7-758"
  },
  "headline": "Recent advances in the management of lymphangioleiomyomatosis",
  "datePublished": "2018-06-18T15:57:41",
  "dateModified": "2018-06-18T15:57:41",
  "author": [
    {
      "@type": "Person",
      "name": "Kai-Feng Xu"
    },    {
      "@type": "Person",
      "name": "Xinlun Tian"
    },    {
      "@type": "Person",
      "name": "Jay H Ryu"
    }  ],
  "publisher": {
    "@type": "Organization",
    "name": "F1000Research",
    "logo": {
      "@type": "ImageObject",
      "url": "https://f1000research.com/img/AMP/F1000Research_image.png",
      "height": 480,
      "width": 60
    }
  },
  "image": {
    "@type": "ImageObject",
    "url": "https://f1000research.com/img/AMP/F1000Research_image.png",
    "height": 1200,
    "width": 150
  },
  "description": "Lymphangioleiomyomatosis is a rare disorder that predominantly affects women and is characterized by progressive cystic changes in the lung, leading to gradually worsening shortness of breath and lung function impairment. Pleural complications such as pneumothorax and chylothorax commonly occur in these patients. Lymphangioleiomyomatosis can occur as a form of lung involvement in tuberous sclerosis complex or as a sporadic form (without tuberous sclerosis complex). Etiology in both forms of this disease centers on mutations in the tuberous sclerosis genes. Advances in our understanding of the regulatory role of tuberous sclerosis gene products (hamartin/tuberin) in the mechanistic target of rapamycin (mTOR) signaling pathway have led to the identification of effective therapy (mTOR inhibitors) for a rare disorder, once considered uniformly fatal. Here, we summarize the evolution of current concepts regarding lymphangioleiomyomatosis with an emphasis on recent advances and unresolved issues."
}
</script> <div class="o-layout o-layout--right-gutter"> <div id=article_secondary-column class="p-article__main o-layout__item u-font-size--legal u-2/3@article not-expanded "> <div class=float-left> <script type="application/ld+json">
  {
    "@context": "http://schema.org",
    "@type": "BreadcrumbList",
    "itemListElement": [
              {
          "@type": "ListItem",
          "position": "1",
          "item": {
            "@id": "https://f1000research.com/",
            "name": "Home"
          }
        },              {
          "@type": "ListItem",
          "position": "2",
          "item": {
            "@id": "https://f1000research.com/browse/articles",
            "name": "Browse"
          }
        },              {
          "@type": "ListItem",
          "position": "3",
          "item": {
            "@id": "https://f1000research.com/articles/7-758/v1",
            "name": "Recent advances in the management of lymphangioleiomyomatosis"
          }
        }          ]
  }
  </script> <div class="breadcrumbs js-breadcrumbs"> <a href="/" class=f1r-standard-link>Home</a> <span class=item_separator></span> <a href="/browse/articles" class=f1r-standard-link>Browse</a> <span class=item_separator></span> Recent advances in the management of lymphangioleiomyomatosis </div> </div> <div class="article-badges-container u-mb--2"> <div class=crossmark-new> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js"></script> <a data-target=crossmark><img height=30 width=150 src="https://crossmark-cdn.crossref.org/widget/v2.0/logos/CROSSMARK_Color_horizontal.svg"/></a> </div> <div id=crossmark-dialog style="display: none;" title=""> <iframe id=crossmark-dialog-frame frameborder=0></iframe> </div> <div class=clearfix></div> </div> <div class=article-interaction-container> <div id=main-article-count-box class=article-count-box> <div class="article-metrics-wrapper metrics-icon-wrapper" data-version-id=15851 data-id=14564 data-downloads="" data-views="" data-scholar="10.12688/f1000research.14564.1" data-recommended="" data-doi="10.12688/f1000research.14564.1" data-f1r-ga-helper="Article Page Metrics (Desktop)"> <span class="metrics-on-browse article-metrics-icon f1r-icon icon-89_metrics"></span> <div class="count-title article-metrics-text">ALL Metrics</div> <div class=js-article-metrics-container></div> </div> <div> <div class=count-delimiter></div> <div title="Total views from F1000Research and PubMed Central"> <div class="count-container view-count js-views-count">-</div> <div class=count-title><span class="count-title-icon count-title-views-icon"></span>Views</div> </div> <div class=download-counts hidden> <div class=count-delimiter></div> <div title="Total downloads from F1000Research and PubMed Central"> <div class="count-container js-downloads-count"></div> <div class=count-title><span class="count-title-icon f1r-icon icon-76_download_file"></span>Downloads</div> </div> </div> </div> </div> <div id=main-article-interaction-box class="article-interaction-box has-control-tab"> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-102_download_pdf"></span> <a href="https://f1000research.com/articles/7-758/v1/pdf?article_uuid=ad2279cf-8dd6-4a13-b7e7-f948f36c01ec" title="Download PDF" class="button-link download pdf-download-helper" target=_blank>Get PDF</a> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-103_download_xml"></span> <a id=download-xml href="#" class="button-link download" title="Download XML">Get XML</a> </div> </div> <div class="article-interaction-info article-page"> <div class="cite-article-popup-wrapper article-page-interaction-box"> <div class="article-interaction-button cite-article-button" title="Cite this article" data-windowref=cite-article-popup-14564-1> <span class="f1r-icon icon-82_quote"></span> <a href="#" class="button-link cite-article-popup-link" title="Cite Article">Cite</a> </div> <div id=cite-article-popup-14564-1 class="popup-window-wrapper is-hidden"> <div class=cite-popup-background></div> <div class="popup-window top-popup cite-this-article-box research-layout"> <div class="popup-window-title small cite-title">How to cite this article</div> <span id=cite-article-text-14564-1 data-test-id=copy-citation_text> <span class="article-title-and-info in-popup">Xu KF, Tian X and Ryu JH. Recent advances in the management of lymphangioleiomyomatosis [version 1; peer review: 4 approved]</span>. <i>F1000Research</i> 2018, <b>7</b>(F1000 Faculty Rev):758 (<a class=new-orange href="https://doi.org/10.12688/f1000research.14564.1" target=_blank>https://doi.org/10.12688/f1000research.14564.1</a>) </span> <div class="popup-window-title small margin-top-20 margin-bottom-20 note"> <strong>NOTE:</strong> it is important to ensure the information in square brackets after the title is included in all citations of this article. </div> <div class=float-right> <button class="secondary no-fill orange-text-and-border margin-right-20 close-cite-popup uppercase">Close</button> <button id=copy-citation-details class="secondary orange copy-cite-article-version uppercase js-clipboard" title="Copy the current citation details to the clipboard." data-clipboard-target="#cite-article-text-14564-1" data-test-id=copy-citation_button>Copy Citation Details</button> </div> </div> </div> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-76_download_file"></span> <a id=export-citation href="#" class="button-link download" title="Export Citation">Export</a> </div> <div class="modal-window-wrapper is-hidden"> <div id=export-citation-popup class="modal-window padding-20"> <div class=modal-window-close-button></div> <div class=modal-window-title>Export Citation</div> <div class=modal-window-row> <div> <input type=radio name=export-citation-option value=WORKSPACE /> <span class=radio-label>Sciwheel</span> </div> <div> <input type=radio name=export-citation-option value=ENDNOTE /> <span class=radio-label>EndNote</span> </div> <div> <input type=radio name=export-citation-option value=REF_MANAGER /> <span class=radio-label>Ref. Manager</span> </div> <div> <input type=radio name=export-citation-option value=BIBTEX /> <span class=radio-label>Bibtex</span> </div> <div> <input type=radio name=export-citation-option value=PROCITE /> <span class=radio-label>ProCite</span> </div> <div> <input type=radio name=export-citation-option value=SENTE /> <span class=radio-label>Sente</span> </div> </div> <div class=modal-window-footer> <button class=general-white-orange-button id=export-citation-submit>EXPORT</button> </div> <div class=default-error style="display: none;">Select a format first</div> </div> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-90_track"></span> <a class="button-link track-article" data-article-id=14564 id=track-article-signin-14564 title="Receive updates on new activity such as publication of new versions, peer reviews or author responses." href="/login?originalPath=/trackArticle/14564?target=/articles/7-758/v1">Track</a> </div> </div> <div class="article-interaction-info article-page"> <div class="article-interaction-button email-article"> <span class="f1r-icon icon-6_email"></span> <a href="#" class=button-link title="Email this article">Email</a> </div> <div class="email-article-version-container small-tooltip _chrome-fix"> <div class=close-icon><span class="f1r-icon icon-3_close_big"></span></div> <script src='https://www.recaptcha.net/recaptcha/api.js'></script> <form class="recommend-version-form research-layout"> <p>All fields are required.</p> <input name=versionId type=hidden value=15851 /> <input name=articleId type=hidden value=14564 /> <input name=senderName class="form-input-field reg-form" value="" type=text placeholder="Your name"/> <input name=senderEmail class="form-input-field reg-form margin-top" value="" type=text placeholder="Your email address"/> <textarea name=recipientEmails class="form-textarea-field ninetynine-percent-wide margin-top no-resize" placeholder="Recipient email address(es) (comma delimited)"></textarea> <input class="form-input-field reg-form margin-top" name=subject type=text value="Interesting article on F1000Research" placeholder=Subject /> <textarea name=message class="form-textarea-field reg-form margin-top no-resize">I thought this article from F1000Research (https://f1000research.com) would be of interest to you.</textarea> <div class="g-recaptcha margin-top" data-sitekey=6LcHqxoUAAAAANP3_0TzpGG6qFvl4DhbUcuRzw7W></div> <input value="" name=captcha type=hidden /> <p>A full article citation will be automatically included.</p> <p><img class="ticker-email-article-details hidden" src="/img/ticker.gif" alt=loading /></p> <button class="secondary orange margin-bottom" data-test-id=version_share_email_send>SEND EMAIL</button> <div class="orange-message margin-bottom is-hidden" data-test-id=version_share_email_message></div> </form> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-34_share"></span> <a href="#" class="button-link last addthis_button share-article" title="Share this article">Share</a> </div> </div> </div> <div id=article-interaction-control-tab class=article-interaction-control-tab> <div id=hide-article-interaction class=article-interaction-control title="Hide Toolbox">&#9644;</div> <div id=show-article-interaction class="article-interaction-control open" title="Show Toolbox">&#10010;</div> </div> </div> <div class="article-header-information article-page"> <div class="f1r-article-mobile article-heading-bar"></div> <div class="article-type article-display">Review </div> <div class="article-title-and-info article-view highlighted-article" id=anchor-title> <h1>Recent advances in the management of lymphangioleiomyomatosis</h1><span class=other-info> [version 1; peer review: 4 approved]</span> </div> <div class=article-subtitle></div> <div class=f1r-article-desk> <div class="authors _mdl-layout"><span class="">Kai-Feng Xu<a href="https://orcid.org/0000-0002-7662-531X" target=_blank id=author-orcid-0><span class=orcid-logo-for-author-list></span></a><div class="mdl-tooltip mdl-tooltip--wider" for=author-orcid-0><span class=orcid-logo-for-author-list></span> https://orcid.org/0000-0002-7662-531X</div><sup>1</sup>,&nbsp;</span><span class="">Xinlun Tian<sup>1</sup>,&nbsp;</span><span class=""><a href="mailto:ryu.jay@mayo.edu" title="Send email" class="cauthor research-layout"><span class='f1r-icon icon-6_email orange'></span><span>Jay H Ryu</span></a><a href="https://orcid.org/0000-0002-9576-2272" target=_blank id=author-orcid-2><span class=orcid-logo-for-author-list></span></a><div class="mdl-tooltip mdl-tooltip--wider" for=author-orcid-2><span class=orcid-logo-for-author-list></span> https://orcid.org/0000-0002-9576-2272</div><sup>2</sup></span></div> </div> <div class=f1r-article-mobile> <div class="authors _mdl-layout"><span class="">Kai-Feng Xu<a href="http://orcid.org/0000-0002-7662-531X" target=_blank id=mauthor-orcid-0><span class=orcid-logo-for-author-list></span></a><div class="mdl-tooltip mdl-tooltip--wider" for=mauthor-orcid-0><span class=orcid-logo-for-author-list></span> https://orcid.org/0000-0002-7662-531X</div><sup>1</sup>,&nbsp;</span><span class="">Xinlun Tian<sup>1</sup>,&nbsp;</span><span class=""><a href="mailto:ryu.jay@mayo.edu" title="Send email" class="cauthor research-layout"><span class='f1r-icon icon-6_email orange'></span><span>Jay H Ryu</span></a><a href="http://orcid.org/0000-0002-9576-2272" target=_blank id=mauthor-orcid-2><span class=orcid-logo-for-author-list></span></a><div class="mdl-tooltip mdl-tooltip--wider" for=mauthor-orcid-2><span class=orcid-logo-for-author-list></span> https://orcid.org/0000-0002-9576-2272</div><sup>2</sup></span></div> </div> <div class=f1r-article-mobile> <div class=article-pubinfo-mobile> PUBLISHED 18 Jun 2018 </div> </div> <span class=Z3988 title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info:ofi/fmt:kev:mtx:journal&amp;rft_id=info:doi/10.12688%2Ff1000research.14564.1"></span> <div class=f1r-article-desk> <div class="contracted-details first"> <a href="#" class="contracted-details-label author-affiliations"><span class=contracted></span>Author details</a> <a href="#" class=section-title>Author details</a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details affiliations is-hidden"> <sup>1</sup> Department of Respiratory Medicine, Peking Union Medical College Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing , China<br/> <sup>2</sup> Division of Pulmonary and Critical Care Medicine, Mayo Clinic , Rochester, MN, USA<br/> <p> <div class=margin-bottom> Kai-Feng Xu <br/> <span>Roles: </span> Conceptualization, Methodology, Project Administration, Validation, Visualization, Writing – Original Draft Preparation, Writing – Review & Editing </div> <div class=margin-bottom> Xinlun Tian <br/> <span>Roles: </span> Conceptualization, Project Administration, Visualization, Writing – Original Draft Preparation, Writing – Review & Editing </div> <div class=margin-bottom> Jay H Ryu <br/> <span>Roles: </span> Conceptualization, Methodology, Project Administration, Supervision, Validation, Visualization, Writing – Review & Editing </div> </p> </div> </div> </div> <div class=f1r-article-mobile> <div class="article-page-section-box margin-bottom-40 research-layout"> <span class=box-title> <span class="f1r-icon icon-85_peer_review"></span> OPEN PEER REVIEW </span> <button class="tertiary grey float-right" data-scrollto=article-reports>DETAILS</button> <div class="status-row referee-reports-container"> REVIEWER STATUS <span class=status-icons> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved data-refInfo=35411-34947></span> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved data-refInfo=35410-34950></span> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved data-refInfo=35413-34948></span> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved data-refInfo=35412-34949></span> </span> </div> </div> </div> </div> <h2 class="article-headings article-page-abstract" id=anchor-abstract> <span class="f1r-article-mobile-inline abstract-heading-border"></span> Abstract </h2> <div class="article-abstract article-page-general-text-mobile research-layout"> <div class="abstract-text is-expanded"> Lymphangioleiomyomatosis is a rare disorder that predominantly affects women and is characterized by progressive cystic changes in the lung, leading to gradually worsening shortness of breath and lung function impairment. Pleural complications such as pneumothorax and chylothorax commonly occur in these patients. Lymphangioleiomyomatosis can occur as a form of lung involvement in tuberous sclerosis complex or as a sporadic form (without tuberous sclerosis complex). Etiology in both forms of this disease centers on mutations in the tuberous sclerosis genes. Advances in our understanding of the regulatory role of tuberous sclerosis gene products (hamartin/tuberin) in the mechanistic target of rapamycin (mTOR) signaling pathway have led to the identification of effective therapy (mTOR inhibitors) for a rare disorder, once considered uniformly fatal. Here, we summarize the evolution of current concepts regarding lymphangioleiomyomatosis with an emphasis on recent advances and unresolved issues. </div> <div class=abstract-for-mobile> <div class="margin-top-30 padding-bottom-30 research-layout is-centered"> <button class="primary orange-text white-bg bigger-text abstract-expand-button-mobile with-border show" style="display: none;"> READ ALL <span class="f1r-icon icon-14_more_small orange vmiddle big"></span> </button> <button class="primary orange-text white-bg bigger-text abstract-expand-button-mobile with-border hide"> READ LESS <span class="f1r-icon icon-10_less_small orange vmiddle big"></span> </button> </div> </div> </div> <div class=clearfix></div> <div class="article-context no-divider"> <div class="article-abstract article-page-general-text-mobile research-layout generated-article-body"> <h2 class=main-title>Keywords</h2> <p class="u-mb--0 u-pb--2"> Angiomyolipoma, Chylothorax, Lung transplantation, Lymphangioleiomyomatosis, Pneumothorax, Pulmonary rehabilitation, Rapamycin, Sirolimus, Tuberous sclerosis complex </p> </div> </div> <div class=article-information> <span class="info-separation padding-bottom"> <div id=corresponding-author-icon class="email-icon float-left"> <span class="f1r-icon icon-6_email orange"></span> <div id=corresponding-author-window class="margin-top-20 popup-window-wrapper is-hidden"> <div class="popup-window corresponding-authors-popup"> <div class=corresponding-author-container> <div class="popup-window-title small">Corresponding Author(s)</div> <div class=authors> Jay H Ryu (<a href="mailto:ryu.jay@mayo.edu">ryu.jay@mayo.edu</a>) </div> </div> <div class="margin-top margin-bottom float-left"> <button id=close-popup-window class=general-white-orange-button>Close</button> </div> </div> </div> </div> <span class="icon-text float-left" data-test-id=box-corresponding-author> <b>Corresponding author:</b> Jay H Ryu </span> <div class=clearfix></div> </span> <span class="info-separation padding-bottom competing-interests-display"> <span class=competing-interests-title>Competing interests:</span> No competing interests were disclosed. </span> <div class="info-separation padding-bottom grant-information-display"> <span class=grant-information-title>Grant information:</span> The work of K-FX and XT was supported by the National Nature Science Foundation of China (81570061), the National Key Research and Development Program of China (2016YFC0901502), the Beijing Municipal Science and Technology Project (Z151100003915126), and the Chinese Academy of Medical Sciences (CAMS) Initiative for Innovative Medicine (2017-12M-2-001). <br/> </div> <span class="f1r-article-desk info-separation padding-bottom"> <span class="copywrite-icon float-left"> <span class="f1r-icon icon-100_open_access"></span> </span> <span class="icon-text float-left" data-test-id=box-copyright-text> <b>Copyright:</b>&nbsp; © 2018 Xu KF <em>et al</em>. This is an open access article distributed under the terms of the <a href="http://creativecommons.org/licenses/by/4.0/" target=_blank data-test-id=box-licence-link>Creative Commons Attribution License</a>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. </span> <div class=clearfix></div> </span> <span class="info-separation padding-bottom" data-test-id=box-how-to-cite> <b>How to cite:</b> <span class="article-title-and-info in-article-box"> Xu KF, Tian X and Ryu JH. Recent advances in the management of lymphangioleiomyomatosis [version 1; peer review: 4 approved]</span>. <i>F1000Research</i> 2018, <b>7</b>(F1000 Faculty Rev):758 (<a href="https://doi.org/10.12688/f1000research.14564.1" target=_blank>https://doi.org/10.12688/f1000research.14564.1</a>) </span> <span class=info-separation data-test-id=box-first-published><b>First published:</b> 18 Jun 2018, <b>7</b>(F1000 Faculty Rev):758 (<a href="https://doi.org/10.12688/f1000research.14564.1" target=_blank>https://doi.org/10.12688/f1000research.14564.1</a>)</span> <span class=info-separation data-test-id=box-latest-published><b>Latest published:</b> 18 Jun 2018, <b>7</b>(F1000 Faculty Rev):758 (<a href="https://doi.org/10.12688/f1000research.14564.1" target=_blank>https://doi.org/10.12688/f1000research.14564.1</a>)</span> </div> <div class=clearfix></div> <div id=article-context class=article-context> <div id=article1-body class=generated-article-body><h2 class=main-title id=d15540e174>Introduction</h2><p class="" id=d15540e177>Lymphangioleiomyomatosis (LAM) is a rare disease that occurs primarily in women and manifests as diffuse cystic changes in the lung<sup><a href="#ref-1">1</a>,<a href="#ref-2">2</a></sup>. The presenting symptoms may include dyspnea or chest pain (often related to spontaneous pneumothorax) or both<sup><a href="#ref-3">3</a>,<a href="#ref-4">4</a></sup>. Some patients may present for evaluation of imaging abnormalities, including cystic lung disease, pleural effusion, or renal tumor (associated renal angiomyolipomas, or AML) in the absence of symptoms.</p><p class="" id=d15540e194>LAM can be sporadic or occur in patients with a heritable disorder, tuberous sclerosis complex (TSC), and had been considered a lethal disorder with no effective therapy. In 2010, the European Respiratory Society (ERS) published the first clinical guidelines for the diagnosis and management of LAM<sup><a href="#ref-3">3</a></sup>. In 2011, sirolimus (rapamycin) therapy was demonstrated to stabilize lung function in patients with LAM<sup><a href="#ref-5">5</a></sup>. Currently, LAM is considered a low-grade, metastasizing neoplasm<sup><a href="#ref-1">1</a></sup>. Advances in our understanding of the disease process in recent years have profoundly changed the management of LAM and the prognosis for affected patients. <a href="#T1">Table 1</a> outlines the major events that have influenced clinical practice in recent years<sup><a href="#ref-3">3</a>,<a href="#ref-5">5</a>–<a href="#ref-11">11</a></sup>. In this review, we aim to summarize the recent evolution of concepts concerning the state-of-the-art management of LAM.</p><a name=T1 class=n-a></a><div class="table-wrap panel clearfix"><div class=caption><h3>Table 1. Recent landmark events in the management of lymphangioleiomyomatosis.</h3></div><table xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class=article-table frame=below><a name=d15540e233 class=n-a></a><thead><a name=d15540e235 class=n-a></a><tr><a name=d15540e237 class=n-a></a><th align=left colspan=1 rowspan=1 valign=top><a name=d15540e239 class=n-a></a>Year</th><th align=left colspan=1 rowspan=1 valign=top><a name=d15540e242 class=n-a></a>Events</th></tr></thead><tbody><a name=d15540e247 class=n-a></a><tr><a name=d15540e249 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d15540e251 class=n-a></a>2008</td><td align=left colspan=1 rowspan=1 valign=top><a name=d15540e254 class=n-a></a>Sirolimus is demonstrated to induce regression of TSC- or sporadic LAM-associated renal angiomyolipomas and improve<br class=br>spirometric measurements in some patients with LAM<sup><a href="#ref-6">6</a></sup>.</td></tr><tr><a name=d15540e264 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d15540e266 class=n-a></a>2010</td><td align=left colspan=1 rowspan=1 valign=top><a name=d15540e269 class=n-a></a>The European Respiratory Society publishes the first clinical guidelines for the diagnosis and management of LAM<sup><a href="#ref-3">3</a></sup>.</td></tr><tr><a name=d15540e277 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d15540e279 class=n-a></a>2011</td><td align=left colspan=1 rowspan=1 valign=top><a name=d15540e282 class=n-a></a>Clinical trial demonstrates the efficacy and safety of sirolimus therapy in patients with sporadic and TSC-associated LAM<sup><a href="#ref-5">5</a></sup>.</td></tr><tr><a name=d15540e290 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d15540e292 class=n-a></a>2013</td><td align=left colspan=1 rowspan=1 valign=top><a name=d15540e295 class=n-a></a>Updated international consensus statement on the diagnosis and management of TSC is published<sup><a href="#ref-7">7</a>,<a href="#ref-8">8</a></sup>.</td></tr><tr><a name=d15540e306 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d15540e308 class=n-a></a>2014</td><td align=left colspan=1 rowspan=1 valign=top><a name=d15540e311 class=n-a></a>Sirolimus is approved for LAM treatment in Japan.</td></tr><tr><a name=d15540e316 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d15540e318 class=n-a></a>2015</td><td align=left colspan=1 rowspan=1 valign=top><a name=d15540e321 class=n-a></a>Sirolimus is approved for LAM treatment in the USA.</td></tr><tr><a name=d15540e325 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d15540e327 class=n-a></a>2015</td><td align=left colspan=1 rowspan=1 valign=top><a name=d15540e330 class=n-a></a>LAM is listed in the 2015 World Health Organization Classification of Lung Tumors<sup><a href="#ref-9">9</a></sup>.</td></tr><tr><a name=d15540e338 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d15540e340 class=n-a></a>2016</td><td align=left colspan=1 rowspan=1 valign=top><a name=d15540e343 class=n-a></a>ATS/JRS LAM clinical practice guidelines are published<sup><a href="#ref-10">10</a></sup>.</td></tr><tr><a name=d15540e351 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d15540e353 class=n-a></a>2017</td><td align=left colspan=1 rowspan=1 valign=top><a name=d15540e356 class=n-a></a>ATS/JRS LAM expanded clinical practice guidelines are published<sup><a href="#ref-11">11</a></sup>.</td></tr></tbody></table><div class=table-wrap-foot><div class=footnote><a name=d15540e368 class=n-a></a><p id=tfn1> ATS, American Thoracic Society; JRS, Japanese Respiratory Society; LAM, lymphangioleiomyomatosis; TSC, tuberous sclerosis complex.</p></div></div></div></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d15540e379>Sirolimus therapy for lymphangioleiomyomatosis</h2><p class="" id=d15540e382>Sirolimus, or rapamycin, inhibits the mechanistic target of rapamycin (mTOR) signaling pathway and currently plays a central role in the treatment of LAM. The molecular pathogenesis of LAM is based on <i>TSC2</i> gene mutations and their effect on the mTOR pathway, which is normally controlled by the protein complex (hamartin/tuberin) encoded by <i>TSC1</i> and <i>TSC2</i> genes, respectively<sup><a href="#ref-12">12</a>,<a href="#ref-13">13</a></sup>. When the <i>TSC2</i> or <i>TSC1</i> gene is mutated, the resulting protein complex fails in its role as an upstream negative regulator of mTOR and results in its constitutive activation<sup><a href="#ref-14">14</a></sup>. This mTOR activation, in turn, results in unregulated cell growth.</p><p class="" id=d15540e412>Based on the discovery of <i>TSC2</i> mutation in patients with sporadic LAM and the mechanism of action of sirolimus, clinical trials were initiated assessing the efficacy of sirolimus therapy for not only TSC-related tumors but also LAM. In 2008, Bissler <i>et al</i>. published the first clinical trial on the use of sirolimus for renal AMLs in patients with TSC as well as sporadic LAM<sup><a href="#ref-6">6</a></sup>. In the 12-month treatment period, sirolimus significantly reduced the size of AMLs. The pulmonary function measurements for the 11 LAM patients in the study improved as well. Subsequently, a randomized placebo-controlled study of sirolimus for LAM—Multicenter International Lymphangioleiomyomatosis Efficacy of Sirolimus (MILES) study—enrolled 89 patients<sup><a href="#ref-5">5</a></sup>. The forced expiratory volume at 1 second (FEV<sub>1</sub>) increased or remained stable during 12 months of treatment. The level of serum vascular endothelial growth factor-D (VEGF-D), a biomarker reflecting disease activity, decreased significantly during treatment with sirolimus.</p><p class="" id=d15540e432>Sirolimus has now been widely administered to patients with LAM. Multiple additional clinical studies on the use of sirolimus for LAM have been published, although the sample sizes of the studies were relatively small because of the rarity of this disease<sup><a href="#ref-15">15</a></sup>. Overall, sirolimus therapy was demonstrated to stabilize lung function, improve quality of life, reduce the size of chylothorax, decrease the volume of renal AMLs, and decrease serum VEGF-D level<sup><a href="#ref-16">16</a>–<a href="#ref-23">23</a></sup>.</p><div class=section><a name=d15540e446 class=n-a></a><h3 class=section-title>Indications for sirolimus therapy in lymphangioleiomyomatosis</h3><p class="" id=d15540e451>Diffuse cystic lung disease can be seen in disorders other than LAM, and the differential diagnosis of diffuse cystic lung disease has been reviewed elsewhere<sup><a href="#ref-2">2</a>,<a href="#ref-24">24</a></sup>. The diagnosis of LAM is classified as “definite”, “probable”, or “possible” according to the criteria outlined in the 2010 ERS guidelines<sup><a href="#ref-3">3</a></sup>. The diagnostic criteria for definite LAM were updated recently in the American Thoracic Society/Japanese Respiratory Society (ATS/JRS) guidelines published in 2017. Accordingly, a definite diagnosis of LAM can be established when a patient has compatible clinical and radiological findings—diffuse cystic lung disease depicted on high-resolution computed tomography (CT) of the chest—combined with one of the following features: presence of TSC, renal AMLs, chylothorax, lymphangioleiomyomas, elevated serum VEGF-D level, presence of LAM cells demonstrated in effusions or lymph nodes, or histopathological confirmation by biopsy of lung or extrapulmonary lesion. Patients with compatible clinical and radiological features can be diagnosed with “probable” LAM in the absence of additional diagnostic criteria.</p><p class="" id=d15540e465>Sirolimus therapy is currently recommended for patients with a definite diagnosis of LAM who manifest an abnormal (FEV<sub>1</sub> of less than 70% of the predicted value) or declining pulmonary function<sup><a href="#ref-10">10</a></sup>. Other indications for the use of sirolimus in patients with LAM may include symptomatic chylothorax or chylous ascites<sup><a href="#ref-10">10</a></sup>, renal AMLs<sup><a href="#ref-6">6</a></sup>, retroperitoneal or pelvic lymphangioleiomyomas, and other TSC-related lesions<sup><a href="#ref-15">15</a></sup>.</p></div><div class=section><a name=d15540e489 class=n-a></a><h3 class=section-title>Optimal dosage of sirolimus therapy in lymphangioleiomyomatosis</h3><p class="" id=d15540e494>Although optimal dosage of sirolimus for LAM has not been defined, the currently favored dosage for LAM is 1–2 mg per day (“low dose”) to achieve a serum trough level of around 5 ng/mL, which is on the lower end of the original target serum trough level in the MILES trial (that is, between 5 and 15 ng/mL). In a retrospective analysis of 98 patients with LAM treated with this dosing regimen at Peking Union Medical College Hospital, the majority of patients achieved a trough serum level of 5–10 ng/mL while about 20% of patients attained a serum trough level of less than 5 ng/mL<sup><a href="#ref-16">16</a></sup>. A study involving 15 patients in Japan suggested that an even lower dosing regimen that achieves a serum trough level of less than 5 ng/mL may provide treatment effects equivalent to those of higher dosing regimens<sup><a href="#ref-25">25</a></sup>. Another study reported no association between the rate of change in FEV<sub>1</sub> and serum sirolimus level<sup><a href="#ref-23">23</a></sup>.</p><p class="" id=d15540e512>We suggest monitoring patients with LAM for progression of the disease while on sirolimus therapy as well as assessing for adverse drug-related effects. Although minimal effective dosage is preferred, higher doses of sirolimus may be needed in patients who continue to manifest disease progression. <a href="#T2">Table 2</a> outlines the suggested monitoring schedule for LAM patients on sirolimus therapy<sup><a href="#ref-26">26</a></sup>.</p><a name=T2 class=n-a></a><div class="table-wrap panel clearfix"><div class=caption><h3>Table 2. Suggested schedule of monitoring assessments for lymphangioleiomyomatosis patients on sirolimus therapy.</h3></div><table xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class=article-table frame=below><a name=d15540e533 class=n-a></a><thead><a name=d15540e535 class=n-a></a><tr><a name=d15540e537 class=n-a></a><th align=left colspan=1 rowspan=1 valign=top><a name=d15540e539 class=n-a></a>Monitoring assessments</th><th align=left colspan=1 rowspan=1 valign=top><a name=d15540e542 class=n-a></a>Prior to<br class=br>therapy</th><th align=left colspan=1 rowspan=1 valign=top><a name=d15540e547 class=n-a></a>Initial 3<br class=br>months</th><th align=left colspan=1 rowspan=1 valign=top><a name=d15540e552 class=n-a></a>Every 6–12<br class=br>months</th><th align=left colspan=1 rowspan=1 valign=top><a name=d15540e557 class=n-a></a>In case of clinical<br class=br>worsening</th></tr></thead><tbody><a name=d15540e564 class=n-a></a><tr><a name=d15540e566 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d15540e568 class=n-a></a>Clinical</td><td align=left colspan=1 rowspan=1 valign=top><a name=d15540e571 class=n-a></a>✓</td><td align=left colspan=1 rowspan=1 valign=top><a name=d15540e574 class=n-a></a>✓</td><td align=left colspan=1 rowspan=1 valign=top><a name=d15540e577 class=n-a></a>✓</td><td align=left colspan=1 rowspan=1 valign=top><a name=d15540e580 class=n-a></a>✓</td></tr><tr><a name=d15540e584 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d15540e586 class=n-a></a>Pulse oximetry</td><td align=left colspan=1 rowspan=1 valign=top><a name=d15540e589 class=n-a></a>✓</td><td align=left colspan=1 rowspan=1 valign=top><a name=d15540e592 class=n-a></a>✓</td><td align=left colspan=1 rowspan=1 valign=top><a name=d15540e595 class=n-a></a>✓</td><td align=left colspan=1 rowspan=1 valign=top><a name=d15540e598 class=n-a></a>✓</td></tr><tr><a name=d15540e602 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d15540e604 class=n-a></a>Six-minute walking distance (6MWD)</td><td align=left colspan=1 rowspan=1 valign=top><a name=d15540e607 class=n-a></a>✓</td><td align=left colspan=1 rowspan=1 valign=top><a name=d15540e610 class=n-a></a></td><td align=left colspan=1 rowspan=1 valign=top><a name=d15540e612 class=n-a></a>✓</td><td align=left colspan=1 rowspan=1 valign=top><a name=d15540e615 class=n-a></a>✓</td></tr><tr><a name=d15540e619 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d15540e621 class=n-a></a>St George Respiratory Questionnaire</td><td align=left colspan=1 rowspan=1 valign=top><a name=d15540e624 class=n-a></a>✓</td><td align=left colspan=1 rowspan=1 valign=top><a name=d15540e627 class=n-a></a></td><td align=left colspan=1 rowspan=1 valign=top><a name=d15540e629 class=n-a></a>✓</td><td align=left colspan=1 rowspan=1 valign=top><a name=d15540e632 class=n-a></a>✓</td></tr><tr><a name=d15540e636 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d15540e638 class=n-a></a>Pulmonary function test</td><td align=left colspan=1 rowspan=1 valign=top><a name=d15540e641 class=n-a></a>✓</td><td align=left colspan=1 rowspan=1 valign=top><a name=d15540e644 class=n-a></a></td><td align=left colspan=1 rowspan=1 valign=top><a name=d15540e646 class=n-a></a>✓</td><td align=left colspan=1 rowspan=1 valign=top><a name=d15540e649 class=n-a></a>✓</td></tr><tr><a name=d15540e654 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d15540e656 class=n-a></a>Serum vascular endothelial growth factor-D (VEGF-D)<br class=br>level</td><td align=left colspan=1 rowspan=1 valign=top><a name=d15540e661 class=n-a></a>✓</td><td align=left colspan=1 rowspan=1 valign=top><a name=d15540e664 class=n-a></a></td><td align=left colspan=1 rowspan=1 valign=top><a name=d15540e666 class=n-a></a>✓<sup><a href="#tfn2">a</a></sup></td><td align=left colspan=1 rowspan=1 valign=top><a name=d15540e672 class=n-a></a>✓<sup><a href="#tfn2">a</a></sup></td></tr><tr><a name=d15540e679 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d15540e681 class=n-a></a>High-resolution computed tomography (HRCT) of chest</td><td align=left colspan=1 rowspan=1 valign=top><a name=d15540e684 class=n-a></a>✓</td><td align=left colspan=1 rowspan=1 valign=top><a name=d15540e687 class=n-a></a></td><td align=left colspan=1 rowspan=1 valign=top><a name=d15540e689 class=n-a></a>✓<sup><a href="#tfn3">b</a></sup></td><td align=left colspan=1 rowspan=1 valign=top><a name=d15540e695 class=n-a></a>✓<sup><a href="#tfn2">a</a></sup></td></tr><tr><a name=d15540e702 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d15540e704 class=n-a></a>Computed tomography/magnetic resonance imaging<br class=br>of abdomen and pelvis</td><td align=left colspan=1 rowspan=1 valign=top><a name=d15540e709 class=n-a></a>✓</td><td align=left colspan=1 rowspan=1 valign=top><a name=d15540e712 class=n-a></a></td><td align=left colspan=1 rowspan=1 valign=top><a name=d15540e714 class=n-a></a>✓<sup><a href="#tfn4">c</a></sup></td><td align=left colspan=1 rowspan=1 valign=top><a name=d15540e720 class=n-a></a>✓<sup><a href="#tfn4">c</a></sup></td></tr><tr><a name=d15540e727 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d15540e729 class=n-a></a>Sirolimus concentration</td><td align=left colspan=1 rowspan=1 valign=top><a name=d15540e732 class=n-a></a></td><td align=left colspan=1 rowspan=1 valign=top><a name=d15540e734 class=n-a></a>✓<sup><a href="#tfn5">d</a></sup></td><td align=left colspan=1 rowspan=1 valign=top><a name=d15540e740 class=n-a></a>✓</td><td align=left colspan=1 rowspan=1 valign=top><a name=d15540e743 class=n-a></a>✓</td></tr><tr><a name=d15540e747 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d15540e749 class=n-a></a>Sirolimus safety<sup><a href="#tfn6">e</a></sup></td><td align=left colspan=1 rowspan=1 valign=top><a name=d15540e755 class=n-a></a></td><td align=left colspan=1 rowspan=1 valign=top><a name=d15540e757 class=n-a></a>✓</td><td align=left colspan=1 rowspan=1 valign=top><a name=d15540e760 class=n-a></a>✓</td><td align=left colspan=1 rowspan=1 valign=top><a name=d15540e763 class=n-a></a>✓</td></tr></tbody></table><div class=table-wrap-foot><div class=footnote><a name=d15540e771 class=n-a></a><p id=tfn2>a Optional depending on the clinical requirements.</p></div><div class=footnote><a name=d15540e780 class=n-a></a><p id=tfn3>b HRCT of the chest can be assessed every 12 months or as clinically indicated.</p></div><div class=footnote><a name=d15540e789 class=n-a></a><p id=tfn4>c If abnormal at baseline or prior to therapy and as clinically indicated.</p></div><div class=footnote><a name=d15540e798 class=n-a></a><p id=tfn5>d The sirolimus dosage should be adjusted during the initial 3 months of treatment, if needed, and when necessary (for example, change in patient’s other medications that may influence serum sirolimus level).</p></div><div class=footnote><a name=d15540e807 class=n-a></a><p id=tfn6>e Including symptoms (rash, oral ulcer, menses, and so on) and laboratory investigations (lipid panel and so on).</p></div><div class=footnote><a name=d15540e817 class=n-a></a><p id=tfn7><span class=warning></span> Modified from Xu and Lo<sup><a href="#ref-26">26</a></sup>.</p></div></div></div></div><div class=section><a name=d15540e830 class=n-a></a><h3 class=section-title>Safety of sirolimus therapy in lymphangioleiomyomatosis</h3><p class="" id=d15540e835>Sirolimus is generally well tolerated in patients with LAM. Common side effects of sirolimus therapy in LAM include acne-like rash, oral ulcer, irregular menses, peripheral edema, diarrhea, hyperlipidemia, and liver enzyme elevations. Sirolimus-associated pneumonitis is rare but can be severe<sup><a href="#ref-21">21</a></sup>. Pulmonary infections were not increased in patients with LAM treated with sirolimus<sup><a href="#ref-5">5</a></sup>. The long-term safety profile of sirolimus therapy has not yet been fully defined.</p></div><div class=section><a name=d15540e847 class=n-a></a><h3 class=section-title>Sirolimus treatment failure</h3><p class="" id=d15540e852>Not all patients with LAM respond to sirolimus therapy. Currently, there is no consensus regarding the definition of treatment failure in LAM. Additionally, alternative therapeutic intervention for such cases is lacking. A phase I trial has been conducted using the combination of sirolimus and hydroxychloroquine (an autophagy inhibitor) and demonstrated the safety of this combination therapy<sup><a href="#ref-27">27</a></sup>. A phase II study of aromatase inhibitor, letrozole, showed this mode of therapy to be safe and well tolerated but, owing in part to under-enrollment of study participants, failed to show efficacy<sup><a href="#ref-28">28</a></sup>. Future studies are needed to clarify the definition of sirolimus treatment failure, underlying mechanisms, and optimal management strategies for affected patients.</p></div></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d15540e867>Pulmonary rehabilitation</h2><p class="" id=d15540e870>Pulmonary rehabilitation is a standard practice for patients with chronic lung diseases<sup><a href="#ref-29">29</a></sup>. It can reduce dyspnea, increase exercise capacity, and improve quality of life. A controlled clinical trial consisting of 40 patients with LAM examined the effects of pulmonary rehabilitation<sup><a href="#ref-30">30</a></sup>. The program included twice-weekly 1-hour sessions of aerobic exercise on a treadmill and muscle strength training along with education for a period of 3 months. The pulmonary rehabilitation group exhibited improved exercise endurance time, quality of life, 6-minute walking distance, and peak oxygen consumption. No cases of pneumothorax or other serious events occurred during exercise. These results suggest that a pulmonary rehabilitation program should be employed in dyspneic patients with LAM. A study of yoga therapy in patients with LAM is ongoing in China (ChiCTR-OON-17012748, <a target=xrefwindow href="http://www.chictr.org.cn/showproj.aspx?proj=21738" id=d15540e880>http://www.chictr.org.cn/showproj.aspx?proj=21738</a>).</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d15540e887>Lung transplantation</h2><p class="" id=d15540e890>Lung transplantation is a treatment option for patients with advanced LAM<sup><a href="#ref-3">3</a></sup>. Similar experiences have been reported from multiple countries on the use of lung transplantation in LAM<sup><a href="#ref-31">31</a>–<a href="#ref-36">36</a></sup>. The ERS guidelines recommended that patients with LAM be considered for lung transplantation when they reach a New York Heart Association (NYHA) functional class of III or IV with severely impaired lung function and exercise capacity<sup><a href="#ref-3">3</a></sup>. Prior pleurodesis and thoracic surgical procedures are associated with higher rates of bleeding and re-exploration but are not contraindications to lung transplantation<sup><a href="#ref-11">11</a>,<a href="#ref-37">37</a></sup>. The actuarial survival of lung transplant recipients with LAM is 65% at 5 years<sup><a href="#ref-3">3</a></sup>.</p><p class="" id=d15540e919>Sirolimus is a potent immunosuppressant and is commonly used in solid organ transplant recipients to prevent organ rejection. There have been reports of impaired wound healing and wound dehiscence associated with sirolimus therapy<sup><a href="#ref-38">38</a>–<a href="#ref-40">40</a></sup>. Given these concerns, questions have arisen regarding whether sirolimus therapy should be discontinued when patients with LAM are on a waiting list for lung transplantation and the safety of including sirolimus in the post-transplant immunosuppressive regimen.</p><p class="" id=d15540e929>When patients are on a waiting list for lung transplantation, most lung transplant programs advise patients to discontinue sirolimus therapy<sup><a href="#ref-39">39</a></sup>. However, the cessation of sirolimus therapy introduces the risk of disease progression and worsening in lung function in patients with LAM. It has been suggested that keeping patients on sirolimus therapy, particularly at a low-dose regimen, is likely safe for patients awaiting lung transplantation<sup><a href="#ref-39">39</a></sup>. Nonetheless, a consensus exists that sirolimus not be used in the immediate post-lung transplant period to minimize the risk of bronchial anastomotic dehiscence. Long-term benefits of reinitiating sirolimus therapy after bronchial anastomotic healing has occurred remain to be determined. These potential benefits may include prevention of LAM recurrence in the transplanted lung, reducing the risk of pleural complications (for example, chylothorax), and control of extrapulmonary manifestations (for example, renal AMLs).</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d15540e943>Other management issues in lymphangioleiomyomatosis</h2><div class=section><a name=d15540e946 class=n-a></a><h3 class=section-title>Pneumothorax</h3><p class="" id=d15540e951>Pneumothorax occurs commonly in patients with LAM. A National Heart, Lung, and Blood Institute (NHLBI) registry study of 230 patients with LAM reported pneumothorax to have occurred in 55.5% of subjects at enrollment into the study<sup><a href="#ref-4">4</a></sup>. Recurrence of pneumothorax is also common, occurring on average 4.4 times among those with a history of pneumothorax<sup><a href="#ref-4">4</a></sup>. Because the recurrence rate is high, current guidelines recommend pleurodesis at the time of the first episode of pneumothorax<sup><a href="#ref-3">3</a>,<a href="#ref-11">11</a></sup>. However, pleurodesis in patients with LAM has limited efficacy and the recurrence rate of pneumothorax is reported to range between 18% and 32%<sup><a href="#ref-11">11</a>,<a href="#ref-41">41</a></sup>. Therefore, more reliable methods to reduce the risk of recurrent pneumothorax in these patients have been sought. Kurihara <i>et al</i>. reported a new surgical technique using oxidized regenerated cellulose mesh to wrap the visceral pleura in a procedure called “total pleural covering” (TPC)<sup><a href="#ref-42">42</a></sup>. They retrospectively analyzed 43 LAM patients who underwent the TPC procedure (54 hemithoraces), 11 of whom required bilateral lung surgeries. A Kaplan-Meier estimate of recurrence-free hemithorax was 80.8% at 2.5 years.</p></div><div class=section><a name=d15540e985 class=n-a></a><h3 class=section-title>Chylothorax</h3><p class="" id=d15540e990>Chylothorax occurs in about 7–10% of patients with LAM<sup><a href="#ref-4">4</a>,<a href="#ref-43">43</a>,<a href="#ref-44">44</a></sup>. The clinical effects and prognosis associated with chylothorax vary considerably<sup><a href="#ref-43">43</a>,<a href="#ref-45">45</a></sup>. Several different types of lymphatic abnormalities associated with chylothorax have been identified by CT and lymphangiography<sup><a href="#ref-46">46</a></sup>. Iliac or retroperitoneal lymphatic vessel dilation and obstruction of the thoracic duct are most commonly observed. Although the majority of physicians believe that LAM patients with chylothorax should be provided a low-fat or fat-free diet, the use of such dietary maneuvers requires monitoring of the nutritional status to avoid malnutrition<sup><a href="#ref-3">3</a></sup>. Observation or drainage by thoracentesis may be sufficient for patients with a small chylothorax<sup><a href="#ref-3">3</a></sup>. Prior to sirolimus therapy, various surgical techniques, including pleurodesis, serial thoracenteses, and thoracic duct ligation, were employed in patients with varying degrees of efficacy<sup><a href="#ref-43">43</a>,<a href="#ref-47">47</a>,<a href="#ref-48">48</a></sup>.</p><p class="" id=d15540e1033>Currently, the most effective management for chylothorax associated with LAM is considered sirolimus therapy. Initial reports on the beneficial effects of sirolimus therapy in managing chylothorax associated with LAM were published in 2008<sup><a href="#ref-49">49</a>,<a href="#ref-50">50</a></sup>. Subsequent studies have confirmed the effectiveness of sirolimus therapy on controlling chylothorax<sup><a href="#ref-16">16</a>,<a href="#ref-25">25</a>,<a href="#ref-51">51</a>,<a href="#ref-52">52</a></sup>.</p></div><div class=section><a name=d15540e1057 class=n-a></a><h3 class=section-title>Renal angiomyolipoma</h3><p class="" id=d15540e1062>Renal AMLs are found in about 30% of patients with sporadic LAM and 90% of those with TSC-related LAM<sup><a href="#ref-4">4</a></sup>. Previously, the management of renal AMLs included embolization therapy or nephron-sparing surgery for tumors larger than 4 cm<sup>3</sup>. Clinical practice has changed since the advent of mTOR inhibitor therapy (that is, sirolimus or everolimus) for LAM and TSC-related manifestations. It is now well established that sirolimus effectively reduces the size of renal AMLs. In a report from Bissler <i>et al</i>., sirolimus reduced the volume of renal AMLs by about half after 1 year of treatment<sup><a href="#ref-6">6</a></sup>. In a randomized placebo-controlled trial of everolimus for renal AMLs associated with sporadic LAM or TSC (EXIST-2), 42% of patients achieved a response defined as 50% reduction of tumor volume<sup><a href="#ref-53">53</a></sup>. A total of 58% of 112 patients achieved a response during a 4-year extension period of the study, while none of the treated patients experienced bleeding of the tumor or needed nephrectomy<sup><a href="#ref-54">54</a></sup>. Other studies have confirmed the effectiveness of sirolimus therapy for renal AMLs<sup><a href="#ref-16">16</a>,<a href="#ref-17">17</a>,<a href="#ref-22">22</a></sup>.</p></div></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d15540e1103>Pulmonary hypertension</h2><p class="" id=d15540e1106>Pulmonary hypertension (PH) can be seen in patients with LAM with an estimated prevalence of 7% to 8%<sup><a href="#ref-55">55</a>–<a href="#ref-57">57</a></sup>. PH is usually mild to moderate in severity but can be associated with significant impact on functional capacity<sup><a href="#ref-55">55</a>–<a href="#ref-57">57</a></sup>. The mechanisms underlying PH may include hypoxemia (including exertion-related oxygen desaturation) and pulmonary vascular remodeling. Hemodynamic parameters tend to correlate with pulmonary function, especially FEV<sub>1</sub>, diffusion capacity of the lung for carbon monoxide (DLCO), and alveolar-arterial oxygen (PA-aO<sub>2</sub>) gradient. A recent report suggests that PH may improve with sirolimus therapy<sup><a href="#ref-58">58</a></sup>.</p><div class=section><a name=d15540e1133 class=n-a></a><h3 class=section-title>Air travel</h3><p class="" id=d15540e1138>Ambient barometric pressure change that occurs during air travel has raised concerns regarding the risk of pneumothorax during flight for patients with cystic lung disease such as LAM. A survey study of 327 patients with LAM reported a rate of 2.2% for pneumothorax in flight<sup><a href="#ref-59">59</a></sup>. Other reported symptoms during air travel included chest pain, dyspnea, hypoxemia, nausea, dizziness, fatigue, headache, hemoptysis, and anxiety. Another study, of 281 patients with LAM, found a pneumothorax rate of 1.1% per flight<sup><a href="#ref-60">60</a></sup>.</p><p class="" id=d15540e1149>Although the incidence of pneumothorax associated with air travel is low, advice regarding air travel should be formulated carefully on an individual basis<sup><a href="#ref-61">61</a></sup>. Patients with existing pneumothorax should avoid air travel. Patients who have recovered from pneumothorax or thoracic surgery should delay air travel for a period of a few weeks, until full resolution and healing have been achieved. Patients with symptoms of chest pain, severe dyspnea, or low oxygen saturation should be medically evaluated in advance of planned air travel.</p></div><div class=section><a name=d15540e1157 class=n-a></a><h3 class=section-title>Pregnancy</h3><p class="" id=d15540e1162>LAM-associated complications, including pneumothorax and chylothorax, may occur during pregnancy, and concerns have been raised regarding possible association of pregnancy with progression of LAM<sup><a href="#ref-62">62</a>,<a href="#ref-63">63</a></sup>. Women with LAM have also been reported to experience worse pregnancy outcomes, including a greater number of premature births and miscarriages<sup><a href="#ref-62">62</a>,<a href="#ref-63">63</a></sup>.</p><p class="" id=d15540e1179>Women with LAM should be informed of these increased risks associated with pregnancy<sup><a href="#ref-3">3</a></sup>. Patients with mild or moderate LAM will likely tolerate pregnancy better compared with those with more severe disease. The decision to proceed to pregnancy is a personal one that is made on an individual basis after assessing the severity of LAM, potential risks, and other options to pregnancy. During pregnancy, the patient should be monitored carefully by a multidisciplinary team that can optimally manage a high-risk pregnancy.</p><p class="" id=d15540e1186>Sirolimus is included in the C risk category (risk to fetus has not been ruled out, and adverse effect to the fetus has been shown in animal studies but no adequate studies of humans) for US Food and Drug Administration pregnancy labeling. There are reports of successful pregnancy without teratogenicity in solid organ transplant recipients receiving sirolimus. Currently, initiation of contraception is recommended before starting sirolimus therapy and continued for 12 weeks after discontinuation.</p></div><div class=section><a name=d15540e1190 class=n-a></a><h3 class=section-title>Avoidance of exogenous estrogen</h3><p class="" id=d15540e1195>Several lines of observation suggest that estrogen promotes the growth and spread of LAM cells. For example, LAM occurs mostly in women and seems to manifest slowing of disease progression after menopause. There are <i>in vitro</i> data demonstrating that neoplastic potential and survival of LAM cells are enhanced by estrogen<sup><a href="#ref-64">64</a></sup>. Thus, it is generally advised that exogenous estrogen exposure (for example, estrogen replacement therapy) be avoided for patients with LAM.</p></div></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d15540e1209>Summary</h2><p class="" id=d15540e1212>Not long ago, LAM was considered a uniformly fatal lung disease for those who became afflicted with this rare and poorly understood condition. Remarkable progress has occurred, particularly over the past decade, leading to effective medical therapy that prevents progression of disease for most patients. There are unanswered questions regarding the long-term efficacy and safety of mTOR inhibitor therapy for the treatment of LAM. In addition, there is a need to identify other medical treatment options for those patients who experience disease progression despite mTOR inhibition.</p></div><div id=article1-back class=generated-article-footer><div class=back-section><a name=d15540e1 class=n-a></a><h2 class=main-title id=d15775>Competing interests</h2><p class=metadata-entry><a name=d15540e111 class=n-a></a><p id=d15540e112> No competing interests were disclosed.</p></p></div><div class=back-section><a name=d15540e1 class=n-a></a><h2 class=main-title id=d15777>Grant information</h2><p>The work of K-FX and XT was supported by the National Nature Science Foundation of China (81570061), the National Key Research and Development Program of China (2016YFC0901502), the Beijing Municipal Science and Technology Project (Z151100003915126), and the Chinese Academy of Medical Sciences (CAMS) Initiative for Innovative Medicine (2017-12M-2-001).</p></div><div class=back-section><a name=d15540e1219 class=n-a></a><span class="research-layout prime-recommended-wrapper reference-heading"><span class="f1r-icon icon-79_faculty_recommended_badge red vmiddle default-cursor"></span><span class="prime-red big">F1000 recommended</span></span><h2 class=main-title id=d15999>References</h2><div class="section ref-list"><a name=d15540e1219 class=n-a></a><ul><li><a name=ref-1 class=n-a></a><span class=label>1. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/717970481"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d15540e1226 class=n-a></a>McCormack FX, Travis WD, Colby TV, <i> et al.</i>: Lymphangioleiomyomatosis: calling it what it is: a low-grade, destructive, metastasizing neoplasm. <i>Am J Respir Crit Care Med.</i> 2012; <b>186</b>(12): 1210–2. <a target=xrefwindow id=d15540e1237 href="http://www.ncbi.nlm.nih.gov/pubmed/23250499">PubMed Abstract </a> | <a target=xrefwindow id=d15540e1240 href="http://dx.doi.org/10.1164/rccm.201205-0848OE">Publisher Full Text </a> | <a target=xrefwindow id=d15540e1244 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3622443">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/717970481">F1000 Recommendation</a></span></li><li><a name=ref-2 class=n-a></a><span class=label>2. </span>&nbsp;<span class=citation><a name=d15540e1257 class=n-a></a>Ryu JH, Tian X, Baqir M, <i> et al.</i>: Diffuse cystic lung diseases. <i>Front Med.</i> 2013; <b>7</b>(3): 316–27. <a target=xrefwindow id=d15540e1268 href="http://www.ncbi.nlm.nih.gov/pubmed/23666611">PubMed Abstract </a> | <a target=xrefwindow id=d15540e1271 href="http://dx.doi.org/10.1007/s11684-013-0269-z">Publisher Full Text </a></span></li><li><a name=ref-3 class=n-a></a><span class=label>3. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/722035556"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d15540e1280 class=n-a></a>Johnson SR, Cordier JF, Lazor R, <i> et al.</i>: European Respiratory Society guidelines for the diagnosis and management of lymphangioleiomyomatosis. <i>Eur Respir J.</i> 2010; <b>35</b>(1): 14–26. <a target=xrefwindow id=d15540e1291 href="http://www.ncbi.nlm.nih.gov/pubmed/20044458">PubMed Abstract </a> | <a target=xrefwindow id=d15540e1294 href="http://dx.doi.org/10.1183/09031936.00076209">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/722035556">F1000 Recommendation</a></span></li><li><a name=ref-4 class=n-a></a><span class=label>4. </span>&nbsp;<span class=citation><a name=d15540e1307 class=n-a></a>Ryu JH, Moss J, Beck GJ, <i> et al.</i>: The NHLBI lymphangioleiomyomatosis registry: characteristics of 230 patients at enrollment. <i>Am J Respir Crit Care Med.</i> 2006; <b>173</b>(1): 105–11. <a target=xrefwindow id=d15540e1318 href="http://www.ncbi.nlm.nih.gov/pubmed/16210669">PubMed Abstract </a> | <a target=xrefwindow id=d15540e1321 href="http://dx.doi.org/10.1164/rccm.200409-1298OC">Publisher Full Text </a> | <a target=xrefwindow id=d15540e1325 href="http://www.ncbi.nlm.nih.gov/pmc/articles/2662978">Free Full Text </a></span></li><li><a name=ref-5 class=n-a></a><span class=label>5. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/9404956"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d15540e1334 class=n-a></a>McCormack FX, Inoue Y, Moss J, <i> et al.</i>: Efficacy and safety of sirolimus in lymphangioleiomyomatosis. <i>N Engl J Med.</i> 2011; <b>364</b>(17): 1595–606. <a target=xrefwindow id=d15540e1345 href="http://www.ncbi.nlm.nih.gov/pubmed/21410393">PubMed Abstract </a> | <a target=xrefwindow id=d15540e1348 href="http://dx.doi.org/10.1056/NEJMoa1100391">Publisher Full Text </a> | <a target=xrefwindow id=d15540e1352 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3118601">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/9404956">F1000 Recommendation</a></span></li><li><a name=ref-6 class=n-a></a><span class=label>6. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/1099439"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d15540e1366 class=n-a></a>Bissler JJ, McCormack FX, Young LR, <i> et al.</i>: Sirolimus for angiomyolipoma in tuberous sclerosis complex or lymphangioleiomyomatosis. <i>N Engl J Med.</i> 2008; <b>358</b>(2): 140–51. <a target=xrefwindow id=d15540e1377 href="http://www.ncbi.nlm.nih.gov/pubmed/18184959">PubMed Abstract </a> | <a target=xrefwindow id=d15540e1380 href="http://dx.doi.org/10.1056/NEJMoa063564">Publisher Full Text </a> | <a target=xrefwindow id=d15540e1384 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3398441">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/1099439">F1000 Recommendation</a></span></li><li><a name=ref-7 class=n-a></a><span class=label>7. </span>&nbsp;<span class=citation><a name=d15540e1397 class=n-a></a>Northrup H, Krueger DA, International Tuberous Sclerosis Complex Consensus Group: Tuberous Sclerosis Complex Diagnostic Criteria Update: Recommendations of the 2012 International Tuberous Sclerosis Complex Consensus Conference. <i>Pediatr Neurol.</i> 2013; <b>49</b>(4): 243–54. <a target=xrefwindow id=d15540e1405 href="http://www.ncbi.nlm.nih.gov/pubmed/24053982">PubMed Abstract </a> | <a target=xrefwindow id=d15540e1408 href="http://dx.doi.org/10.1016/j.pediatrneurol.2013.08.001">Publisher Full Text </a> | <a target=xrefwindow id=d15540e1411 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4080684">Free Full Text </a></span></li><li><a name=ref-8 class=n-a></a><span class=label>8. </span>&nbsp;<span class=citation><a name=d15540e1420 class=n-a></a>Krueger DA, Northrup H, International Tuberous Sclerosis Complex Consensus Group: Tuberous sclerosis complex surveillance and management: recommendations of the 2012 International Tuberous Sclerosis Complex Consensus Conference. <i>Pediatr Neurol.</i> 2013; <b>49</b>(4): 255–65. <a target=xrefwindow id=d15540e1428 href="http://www.ncbi.nlm.nih.gov/pubmed/24053983">PubMed Abstract </a> | <a target=xrefwindow id=d15540e1431 href="http://dx.doi.org/10.1016/j.pediatrneurol.2013.08.002">Publisher Full Text </a> | <a target=xrefwindow id=d15540e1434 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4058297">Free Full Text </a></span></li><li><a name=ref-9 class=n-a></a><span class=label>9. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/725757738"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d15540e1443 class=n-a></a>Travis WD, Brambilla E, Nicholson AG, <i> et al.</i>: The 2015 World Health Organization Classification of Lung Tumors: Impact of Genetic, Clinical and Radiologic Advances Since the 2004 Classification. <i>J Thorac Oncol.</i> 2015; <b>10</b>(9): 1243–60. <a target=xrefwindow id=d15540e1454 href="http://www.ncbi.nlm.nih.gov/pubmed/26291008">PubMed Abstract </a> | <a target=xrefwindow id=d15540e1457 href="http://dx.doi.org/10.1097/JTO.0000000000000630">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/725757738">F1000 Recommendation</a></span></li><li><a name=ref-10 class=n-a></a><span class=label>10. </span>&nbsp;<span class=citation><a name=d15540e1470 class=n-a></a>McCormack FX, Gupta N, Finlay GR, <i> et al.</i>: Official American Thoracic Society/Japanese Respiratory Society Clinical Practice Guidelines: Lymphangioleiomyomatosis Diagnosis and Management. <i>Am J Respir Crit Care Med.</i> 2016; <b>194</b>(6): 748–61. <a target=xrefwindow id=d15540e1481 href="http://www.ncbi.nlm.nih.gov/pubmed/27628078">PubMed Abstract </a> | <a target=xrefwindow id=d15540e1484 href="http://dx.doi.org/10.1164/rccm.201607-1384ST">Publisher Full Text </a> | <a target=xrefwindow id=d15540e1488 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5803656">Free Full Text </a></span></li><li><a name=ref-11 class=n-a></a><span class=label>11. </span>&nbsp;<span class=citation><a name=d15540e1497 class=n-a></a>Gupta N, Finlay GA, Kotloff RM, <i> et al.</i>: Lymphangioleiomyomatosis Diagnosis and Management: High-Resolution Chest Computed Tomography, Transbronchial Lung Biopsy, and Pleural Disease Management. An Official American Thoracic Society/Japanese Respiratory Society Clinical Practice Guideline. <i>Am J Respir Crit Care Med.</i> 2017; <b>196</b>(10): 1337–48. <a target=xrefwindow id=d15540e1508 href="http://www.ncbi.nlm.nih.gov/pubmed/29140122">PubMed Abstract </a> | <a target=xrefwindow id=d15540e1511 href="http://dx.doi.org/10.1164/rccm.201709-1965ST">Publisher Full Text </a> | <a target=xrefwindow id=d15540e1515 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5694834">Free Full Text </a></span></li><li><a name=ref-12 class=n-a></a><span class=label>12. </span>&nbsp;<span class=citation><a name=d15540e1525 class=n-a></a>Carsillo T, Astrinidis A, Henske EP: Mutations in the tuberous sclerosis complex gene <i>TSC2</i> are a cause of sporadic pulmonary lymphangioleiomyomatosis. <i>Proc Natl Acad Sci U S A.</i> 2000; <b>97</b>(11): 6085–90. <a target=xrefwindow id=d15540e1536 href="http://www.ncbi.nlm.nih.gov/pubmed/10823953">PubMed Abstract </a> | <a target=xrefwindow id=d15540e1539 href="http://dx.doi.org/10.1073/pnas.97.11.6085">Publisher Full Text </a> | <a target=xrefwindow id=d15540e1543 href="http://www.ncbi.nlm.nih.gov/pmc/articles/18562">Free Full Text </a></span></li><li><a name=ref-13 class=n-a></a><span class=label>13. </span>&nbsp;<span class=citation><a name=d15540e1552 class=n-a></a>Krymskaya VP, McCormack FX: Lymphangioleiomyomatosis: A Monogenic Model of Malignancy. <i>Annu Rev Med.</i> 2017; <b>68</b>: 69–83. <a target=xrefwindow id=d15540e1560 href="http://www.ncbi.nlm.nih.gov/pubmed/28099079">PubMed Abstract </a> | <a target=xrefwindow id=d15540e1563 href="http://dx.doi.org/10.1146/annurev-med-050715-104245">Publisher Full Text </a> | <a target=xrefwindow id=d15540e1566 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5663315">Free Full Text </a></span></li><li><a name=ref-14 class=n-a></a><span class=label>14. </span>&nbsp;<span class=citation><a name=d15540e1575 class=n-a></a>El-Hashemite N, Zhang H, Henske EP, <i> et al.</i>: Mutation in <i>TSC2</i> and activation of mammalian target of rapamycin signalling pathway in renal angiomyolipoma. <i>Lancet.</i> 2003; <b>361</b>(9366): 1348–9. <a target=xrefwindow id=d15540e1589 href="http://www.ncbi.nlm.nih.gov/pubmed/12711473">PubMed Abstract </a> | <a target=xrefwindow id=d15540e1593 href="http://dx.doi.org/10.1016/S0140-6736(03)13044-9">Publisher Full Text </a></span></li><li><a name=ref-15 class=n-a></a><span class=label>15. </span>&nbsp;<span class=citation><a name=d15540e1602 class=n-a></a>Xu K, Tian X, Yang Y, <i> et al.</i>: Rapamycin for lymphangioleiomyomatosis: optimal timing and optimal dosage. <i>Thorax.</i> 2018; <b>73</b>(4): 308–10. <a target=xrefwindow id=d15540e1613 href="http://www.ncbi.nlm.nih.gov/pubmed/29438097">PubMed Abstract </a> | <a target=xrefwindow id=d15540e1616 href="http://dx.doi.org/10.1136/thoraxjnl-2017-211135">Publisher Full Text </a></span></li><li><a name=ref-16 class=n-a></a><span class=label>16. </span>&nbsp;<span class=citation><a name=d15540e1625 class=n-a></a>Zhan Y, Shen L, Xu W, <i> et al.</i>: Functional improvements in patients with lymphangioleiomyomatosis after sirolimus: an observational study. <i>Orphanet J Rare Dis.</i> 2018; <b>13</b>(1): 34. <a target=xrefwindow id=d15540e1636 href="http://www.ncbi.nlm.nih.gov/pubmed/29458386">PubMed Abstract </a> | <a target=xrefwindow id=d15540e1639 href="http://dx.doi.org/10.1186/s13023-018-0775-9">Publisher Full Text </a> | <a target=xrefwindow id=d15540e1643 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5819088">Free Full Text </a></span></li><li><a name=ref-17 class=n-a></a><span class=label>17. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/11911959"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d15540e1652 class=n-a></a>Davies DM, de Vries PJ, Johnson SR, <i> et al.</i>: Sirolimus therapy for angiomyolipoma in tuberous sclerosis and sporadic lymphangioleiomyomatosis: a phase 2 trial. <i>Clin Cancer Res.</i> 2011; <b>17</b>(12): 4071–81. <a target=xrefwindow id=d15540e1663 href="http://www.ncbi.nlm.nih.gov/pubmed/21525172">PubMed Abstract </a> | <a target=xrefwindow id=d15540e1666 href="http://dx.doi.org/10.1158/1078-0432.CCR-11-0445">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/11911959">F1000 Recommendation</a></span></li><li><a name=ref-18 class=n-a></a><span class=label>18. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/720485970"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d15540e1680 class=n-a></a>Neurohr C, Hoffmann AL, Huppmann P, <i> et al.</i>: Is sirolimus a therapeutic option for patients with progressive pulmonary lymphangioleiomyomatosis? <i>Respir Res.</i> 2011; <b>12</b>(1): 66. <a target=xrefwindow id=d15540e1691 href="http://www.ncbi.nlm.nih.gov/pubmed/21600034">PubMed Abstract </a> | <a target=xrefwindow id=d15540e1694 href="http://dx.doi.org/10.1186/1465-9921-12-66">Publisher Full Text </a> | <a target=xrefwindow id=d15540e1698 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3116484">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/720485970">F1000 Recommendation</a></span></li><li><a name=ref-19 class=n-a></a><span class=label>19. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/12005956"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d15540e1711 class=n-a></a>Taveira-DaSilva AM, Hathaway O, Stylianou M, <i> et al.</i>: Changes in lung function and chylous effusions in patients with lymphangioleiomyomatosis treated with sirolimus. <i>Ann Intern Med.</i> 2011; <b>154</b>(12): 797–805, W-292-3. <a target=xrefwindow id=d15540e1722 href="http://www.ncbi.nlm.nih.gov/pubmed/21690594">PubMed Abstract </a> | <a target=xrefwindow id=d15540e1725 href="http://dx.doi.org/10.7326/0003-4819-154-12-201106210-00007">Publisher Full Text </a> | <a target=xrefwindow id=d15540e1729 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3176735">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/12005956">F1000 Recommendation</a></span></li><li><a name=ref-20 class=n-a></a><span class=label>20. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/723347495"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d15540e1742 class=n-a></a>Yao J, Taveira-DaSilva AM, Jones AM, <i> et al.</i>: Sustained effects of sirolimus on lung function and cystic lung lesions in lymphangioleiomyomatosis. <i>Am J Respir Crit Care Med.</i> 2014; <b>190</b>(11): 1273–82. <a target=xrefwindow id=d15540e1753 href="http://www.ncbi.nlm.nih.gov/pubmed/25329516">PubMed Abstract </a> | <a target=xrefwindow id=d15540e1756 href="http://dx.doi.org/10.1164/rccm.201405-0918OC">Publisher Full Text </a> | <a target=xrefwindow id=d15540e1760 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4315813">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/723347495">F1000 Recommendation</a></span></li><li><a name=ref-21 class=n-a></a><span class=label>21. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726630482"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d15540e1773 class=n-a></a>Takada T, Mikami A, Kitamura N, <i> et al.</i>: Efficacy and Safety of Long-Term Sirolimus Therapy for Asian Patients with Lymphangioleiomyomatosis. <i>Ann Am Thorac Soc.</i> 2016; <b>13</b>(11): 1912–22. <a target=xrefwindow id=d15540e1784 href="http://www.ncbi.nlm.nih.gov/pubmed/27513278">PubMed Abstract </a> | <a target=xrefwindow id=d15540e1787 href="http://dx.doi.org/10.1513/AnnalsATS.201605-335OC">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726630482">F1000 Recommendation</a></span></li><li><a name=ref-22 class=n-a></a><span class=label>22. </span>&nbsp;<span class=citation><a name=d15540e1800 class=n-a></a>Taveira-DaSilva AM, Jones AM, Julien-Williams P, <i> et al.</i>: Long-Term Effect of Sirolimus on Serum Vascular Endothelial Growth Factor D Levels in Patients With Lymphangioleiomyomatosis. <i>Chest.</i> 2018; <b>153</b>(1): 124–32. <a target=xrefwindow id=d15540e1811 href="http://www.ncbi.nlm.nih.gov/pubmed/28533049">PubMed Abstract </a> | <a target=xrefwindow id=d15540e1814 href="http://dx.doi.org/10.1016/j.chest.2017.05.012">Publisher Full Text </a> | <a target=xrefwindow id=d15540e1818 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5812752">Free Full Text </a></span></li><li><a name=ref-23 class=n-a></a><span class=label>23. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/731932404"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d15540e1827 class=n-a></a>Bee J, Fuller S, Miller S, <i> et al.</i>: Lung function response and side effects to rapamycin for lymphangioleiomyomatosis: a prospective national cohort study. <i>Thorax.</i> 2018; <b>73</b>(4): 369–75. <a target=xrefwindow id=d15540e1838 href="http://www.ncbi.nlm.nih.gov/pubmed/28993539">PubMed Abstract </a> | <a target=xrefwindow id=d15540e1841 href="http://dx.doi.org/10.1136/thoraxjnl-2017-210872">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/731932404">F1000 Recommendation</a></span></li><li><a name=ref-24 class=n-a></a><span class=label>24. </span>&nbsp;<span class=citation><a name=d15540e1855 class=n-a></a>Xu KF, Feng R, Cui H, <i> et al.</i>: Diffuse Cystic Lung Diseases: Diagnostic Considerations. <i>Semin Respir Crit Care Med.</i> 2016; <b>37</b>(3): 457–67. <a target=xrefwindow id=d15540e1866 href="http://www.ncbi.nlm.nih.gov/pubmed/27231867">PubMed Abstract </a> | <a target=xrefwindow id=d15540e1869 href="http://dx.doi.org/10.1055/s-0036-1580690">Publisher Full Text </a></span></li><li><a name=ref-25 class=n-a></a><span class=label>25. </span>&nbsp;<span class=citation><a name=d15540e1878 class=n-a></a>Ando K, Kurihara M, Kataoka H, <i> et al.</i>: Efficacy and safety of low-dose sirolimus for treatment of lymphangioleiomyomatosis. <i>Respir Investig.</i> 2013; <b>51</b>(3): 175–83. <a target=xrefwindow id=d15540e1889 href="http://www.ncbi.nlm.nih.gov/pubmed/23978644">PubMed Abstract </a> | <a target=xrefwindow id=d15540e1892 href="http://dx.doi.org/10.1016/j.resinv.2013.03.002">Publisher Full Text </a></span></li><li><a name=ref-26 class=n-a></a><span class=label>26. </span>&nbsp;<span class=citation><a name=d15540e1901 class=n-a></a>Xu K, Lo BH: Lymphangioleiomyomatosis: differential diagnosis and optimal management. <i>Ther Clin Risk Manag.</i> 2014; <b>10</b>: 691–700. <a target=xrefwindow id=d15540e1909 href="http://www.ncbi.nlm.nih.gov/pubmed/25187723">PubMed Abstract </a> | <a target=xrefwindow id=d15540e1912 href="http://dx.doi.org/10.2147/TCRM.S50784">Publisher Full Text </a> | <a target=xrefwindow id=d15540e1915 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4149398">Free Full Text </a></span></li><li><a name=ref-27 class=n-a></a><span class=label>27. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727301567"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d15540e1924 class=n-a></a>El-Chemaly S, Taveira-Dasilva A, Goldberg HJ, <i> et al.</i>: Sirolimus and Autophagy Inhibition in Lymphangioleiomyomatosis: Results of a Phase I Clinical Trial. <i>Chest.</i> 2017; <b>151</b>(6): 1302–10. <a target=xrefwindow id=d15540e1935 href="http://www.ncbi.nlm.nih.gov/pubmed/28192114">PubMed Abstract </a> | <a target=xrefwindow id=d15540e1938 href="http://dx.doi.org/10.1016/j.chest.2017.01.033">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727301567">F1000 Recommendation</a></span></li><li><a name=ref-28 class=n-a></a><span class=label>28. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727678658"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d15540e1951 class=n-a></a>Lu C, Lee H, Pappas GP, <i> et al.</i>: A Phase II Clinical Trial of an Aromatase Inhibitor for Postmenopausal Women with Lymphangioleiomyomatosis. <i>Ann Am Thorac Soc.</i> 2017; <b>14</b>(6): 919–28. <a target=xrefwindow id=d15540e1962 href="http://www.ncbi.nlm.nih.gov/pubmed/28570161">PubMed Abstract </a> | <a target=xrefwindow id=d15540e1965 href="http://dx.doi.org/10.1513/AnnalsATS.201610-824OC">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727678658">F1000 Recommendation</a></span></li><li><a name=ref-29 class=n-a></a><span class=label>29. </span>&nbsp;<span class=citation><a name=d15540e1978 class=n-a></a>Spruit MA, Singh SJ, Garvey C, <i> et al.</i>: An official American Thoracic Society/European Respiratory Society statement: key concepts and advances in pulmonary rehabilitation. <i>Am J Respir Crit Care Med.</i> 2013; <b>188</b>(8): e13–64. <a target=xrefwindow id=d15540e1989 href="http://www.ncbi.nlm.nih.gov/pubmed/24127811">PubMed Abstract </a> | <a target=xrefwindow id=d15540e1992 href="http://dx.doi.org/10.1164/rccm.201309-1634ST">Publisher Full Text </a></span></li><li><a name=ref-30 class=n-a></a><span class=label>30. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726176062"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d15540e2002 class=n-a></a>Araujo MS, Baldi BG, Freitas CS, <i> et al.</i>: Pulmonary rehabilitation in lymphangioleiomyomatosis: a controlled clinical trial. <i>Eur Respir J.</i> 2016; <b>47</b>(5): 1452–60. <a target=xrefwindow id=d15540e2013 href="http://www.ncbi.nlm.nih.gov/pubmed/26917604">PubMed Abstract </a> | <a target=xrefwindow id=d15540e2016 href="http://dx.doi.org/10.1183/13993003.01683-2015">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726176062">F1000 Recommendation</a></span></li><li><a name=ref-31 class=n-a></a><span class=label>31. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/729085555"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d15540e2029 class=n-a></a>Baldi BG, Samano MN, Campos SV, <i> et al.</i>: Experience of Lung Transplantation in Patients with Lymphangioleiomyomatosis at a Brazilian Reference Centre. <i>Lung.</i> 2017; <b>195</b>(6): 699–705. <a target=xrefwindow id=d15540e2040 href="http://www.ncbi.nlm.nih.gov/pubmed/28823029">PubMed Abstract </a> | <a target=xrefwindow id=d15540e2043 href="http://dx.doi.org/10.1007/s00408-017-0045-y">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/729085555">F1000 Recommendation</a></span></li><li><a name=ref-32 class=n-a></a><span class=label>32. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726076830"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d15540e2056 class=n-a></a>Ando K, Okada Y, Akiba M, <i> et al.</i>: Lung Transplantation for Lymphangioleiomyomatosis in Japan. <i>PLoS One.</i> 2016; <b>11</b>(1): e0146749. <a target=xrefwindow id=d15540e2067 href="http://www.ncbi.nlm.nih.gov/pubmed/26771878">PubMed Abstract </a> | <a target=xrefwindow id=d15540e2070 href="http://dx.doi.org/10.1371/journal.pone.0146749">Publisher Full Text </a> | <a target=xrefwindow id=d15540e2074 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4714890">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726076830">F1000 Recommendation</a></span></li><li><a name=ref-33 class=n-a></a><span class=label>33. </span>&nbsp;<span class=citation><a name=d15540e2087 class=n-a></a>Ussavarungsi K, Hu X, Scott JP, <i> et al.</i>: Mayo clinic experience of lung transplantation in pulmonary lymphangioleiomyomatosis. <i>Respir Med.</i> 2015; <b>109</b>(10): 1354–9. <a target=xrefwindow id=d15540e2098 href="http://www.ncbi.nlm.nih.gov/pubmed/26321137">PubMed Abstract </a> | <a target=xrefwindow id=d15540e2101 href="http://dx.doi.org/10.1016/j.rmed.2015.08.014">Publisher Full Text </a></span></li><li><a name=ref-34 class=n-a></a><span class=label>34. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/733305493"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d15540e2110 class=n-a></a>Nakagiri T, Shintani Y, Minami M, <i> et al.</i>: Lung Transplantation for Lymphangioleiomyomatosis in a Single Japanese Institute, With a Focus on Late-onset Complications. <i>Transplant Proc.</i> 2015; <b>47</b>(6): 1977–82. <a target=xrefwindow id=d15540e2121 href="http://www.ncbi.nlm.nih.gov/pubmed/26293084">PubMed Abstract </a> | <a target=xrefwindow id=d15540e2124 href="http://dx.doi.org/10.1016/j.transproceed.2015.04.103">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/733305493">F1000 Recommendation</a></span></li><li><a name=ref-35 class=n-a></a><span class=label>35. </span>&nbsp;<span class=citation><a name=d15540e2137 class=n-a></a>Benden C, Rea F, Behr J, <i> et al.</i>: Lung transplantation for lymphangioleiomyomatosis: the European experience. <i>J Heart Lung Transplant.</i> 2009; <b>28</b>(1): 1–7. <a target=xrefwindow id=d15540e2148 href="http://www.ncbi.nlm.nih.gov/pubmed/19134523">PubMed Abstract </a> | <a target=xrefwindow id=d15540e2151 href="http://dx.doi.org/10.1016/j.healun.2008.09.014">Publisher Full Text </a></span></li><li><a name=ref-36 class=n-a></a><span class=label>36. </span>&nbsp;<span class=citation><a name=d15540e2161 class=n-a></a>Kpodonu J, Massad MG, Chaer RA, <i> et al.</i>: The US experience with lung transplantation for pulmonary lymphangioleiomyomatosis. <i>J Heart Lung Transplant.</i> 2005; <b>24</b>(9): 1247–53. <a target=xrefwindow id=d15540e2172 href="http://www.ncbi.nlm.nih.gov/pubmed/16143241">PubMed Abstract </a> | <a target=xrefwindow id=d15540e2175 href="http://dx.doi.org/10.1016/j.healun.2004.09.013">Publisher Full Text </a></span></li><li><a name=ref-37 class=n-a></a><span class=label>37. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/732132475"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d15540e2184 class=n-a></a>Weill D, Benden C, Corris PA, <i> et al.</i>: A consensus document for the selection of lung transplant candidates: 2014--an update from the Pulmonary Transplantation Council of the International Society for Heart and Lung Transplantation. <i>J Heart Lung Transplant.</i> 2015; <b>34</b>(1): 1–15. <a target=xrefwindow id=d15540e2195 href="http://www.ncbi.nlm.nih.gov/pubmed/25085497">PubMed Abstract </a> | <a target=xrefwindow id=d15540e2198 href="http://dx.doi.org/10.1016/j.healun.2014.06.014">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/732132475">F1000 Recommendation</a></span></li><li><a name=ref-38 class=n-a></a><span class=label>38. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727917555"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d15540e2211 class=n-a></a>Kaplan B, Qazi Y, Wellen JR: Strategies for the management of adverse events associated with mTOR inhibitors. <i>Transplant Rev (Orlando).</i> 2014; <b>28</b>(3): 126–33. <a target=xrefwindow id=d15540e2219 href="http://www.ncbi.nlm.nih.gov/pubmed/24685370">PubMed Abstract </a> | <a target=xrefwindow id=d15540e2222 href="http://dx.doi.org/10.1016/j.trre.2014.03.002">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727917555">F1000 Recommendation</a></span></li><li><a name=ref-39 class=n-a></a><span class=label>39. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/725246399"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d15540e2235 class=n-a></a>El-Chemaly S, Goldberg HJ, Glanville AR: Should mammalian target of rapamycin inhibitors be stopped in women with lymphangioleiomyomatosis awaiting lung transplantation? <i>Expert Rev Respir Med.</i> 2014; <b>8</b>(6): 657–60. <a target=xrefwindow id=d15540e2243 href="http://www.ncbi.nlm.nih.gov/pubmed/25199529">PubMed Abstract </a> | <a target=xrefwindow id=d15540e2246 href="http://dx.doi.org/10.1586/17476348.2014.956728">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/725246399">F1000 Recommendation</a></span></li><li><a name=ref-40 class=n-a></a><span class=label>40. </span>&nbsp;<span class=citation><a name=d15540e2259 class=n-a></a>Nashan B, Citterio F: Wound healing complications and the use of mammalian target of rapamycin inhibitors in kidney transplantation: a critical review of the literature. <i>Transplantation.</i> 2012; <b>94</b>(6): 547–61. <a target=xrefwindow id=d15540e2267 href="http://www.ncbi.nlm.nih.gov/pubmed/22941182">PubMed Abstract </a> | <a target=xrefwindow id=d15540e2270 href="http://dx.doi.org/10.1097/TP.0b013e3182551021">Publisher Full Text </a></span></li><li><a name=ref-41 class=n-a></a><span class=label>41. </span>&nbsp;<span class=citation><a name=d15540e2279 class=n-a></a>Almoosa KF, Ryu JH, Mendez J, <i> et al.</i>: Management of pneumothorax in lymphangioleiomyomatosis: effects on recurrence and lung transplantation complications. <i>Chest.</i> 2006; <b>129</b>(5): 1274–81. <a target=xrefwindow id=d15540e2290 href="http://www.ncbi.nlm.nih.gov/pubmed/16685019">PubMed Abstract </a> | <a target=xrefwindow id=d15540e2293 href="http://dx.doi.org/10.1378/chest.129.5.1274">Publisher Full Text </a></span></li><li><a name=ref-42 class=n-a></a><span class=label>42. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726764342"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d15540e2303 class=n-a></a>Kurihara M, Mizobuchi T, Kataoka H, <i> et al.</i>: A Total Pleural Covering for Lymphangioleiomyomatosis Prevents Pneumothorax Recurrence. <i>PLoS One.</i> 2016; <b>11</b>(9): e0163637. <a target=xrefwindow id=d15540e2314 href="http://www.ncbi.nlm.nih.gov/pubmed/27658250">PubMed Abstract </a> | <a target=xrefwindow id=d15540e2317 href="http://dx.doi.org/10.1371/journal.pone.0163637">Publisher Full Text </a> | <a target=xrefwindow id=d15540e2321 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5033523">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726764342">F1000 Recommendation</a></span></li><li><a name=ref-43 class=n-a></a><span class=label>43. </span>&nbsp;<span class=citation><a name=d15540e2334 class=n-a></a>Ryu JH, Doerr CH, Fisher SD, <i> et al.</i>: Chylothorax in lymphangioleiomyomatosis. <i>Chest.</i> 2003; <b>123</b>(2): 623–7. <a target=xrefwindow id=d15540e2345 href="http://www.ncbi.nlm.nih.gov/pubmed/12576391">PubMed Abstract </a> | <a target=xrefwindow id=d15540e2348 href="http://dx.doi.org/10.1378/chest.123.2.623">Publisher Full Text </a></span></li><li><a name=ref-44 class=n-a></a><span class=label>44. </span>&nbsp;<span class=citation><a name=d15540e2357 class=n-a></a>Ye L, Jin M, Bai C: Clinical analysis of patients with pulmonary lymphangioleiomyomatosis (PLAM) in mainland China. <i>Respir Med.</i> 2010; <b>104</b>(10): 1521–6. <a target=xrefwindow id=d15540e2365 href="http://www.ncbi.nlm.nih.gov/pubmed/20627505">PubMed Abstract </a> | <a target=xrefwindow id=d15540e2368 href="http://dx.doi.org/10.1016/j.rmed.2010.05.003">Publisher Full Text </a></span></li><li><a name=ref-45 class=n-a></a><span class=label>45. </span>&nbsp;<span class=citation><a name=d15540e2377 class=n-a></a>Taveira-DaSilva AM, Pacheco-Rodriguez G, Moss J: The natural history of lymphangioleiomyomatosis: markers of severity, rate of progression and prognosis. <i>Lymphat Res Biol.</i> 2010; <b>8</b>(1): 9–19. <a target=xrefwindow id=d15540e2385 href="http://www.ncbi.nlm.nih.gov/pubmed/20235883">PubMed Abstract </a> | <a target=xrefwindow id=d15540e2388 href="http://dx.doi.org/10.1089/lrb.2009.0024">Publisher Full Text </a> | <a target=xrefwindow id=d15540e2391 href="http://www.ncbi.nlm.nih.gov/pmc/articles/2883494">Free Full Text </a></span></li><li><a name=ref-46 class=n-a></a><span class=label>46. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727260344"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d15540e2400 class=n-a></a>Zhang C, Chen X, Wen T, <i> et al.</i>: Computed tomography lymphangiography findings in 27 cases of lymphangioleiomyomatosis. <i>Acta Radiol.</i> 2017; <b>58</b>(11): 1342–8. <a target=xrefwindow id=d15540e2411 href="http://www.ncbi.nlm.nih.gov/pubmed/28132530">PubMed Abstract </a> | <a target=xrefwindow id=d15540e2414 href="http://dx.doi.org/10.1177/0284185116688381">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727260344">F1000 Recommendation</a></span></li><li><a name=ref-47 class=n-a></a><span class=label>47. </span>&nbsp;<span class=citation><a name=d15540e2427 class=n-a></a>Kaptanoglu M, Hatipoglu A, Kutluay L, <i> et al.</i>: Bilateral chylothorax caused by pleuropulmonary lymphangiomyomatosis: a challenging problem in thoracic surgery. <i>Scand Cardiovasc J.</i> 2001; <b>35</b>(2): 151–4. <a target=xrefwindow id=d15540e2438 href="http://www.ncbi.nlm.nih.gov/pubmed/11405493">PubMed Abstract </a> | <a target=xrefwindow id=d15540e2441 href="http://dx.doi.org/10.1080/140174301750164934">Publisher Full Text </a></span></li><li><a name=ref-48 class=n-a></a><span class=label>48. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/728494276"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d15540e2451 class=n-a></a>Liu M, Wu B, Cui Y, <i> et al.</i>: Surgical treatment of chylothorax caused by lymphangioleiomyomatosis. <i>J Thorac Dis.</i> 2014; <b>6</b>(2): E11–4. <a target=xrefwindow id=d15540e2462 href="http://www.ncbi.nlm.nih.gov/pubmed/24605238">PubMed Abstract </a> | <a target=xrefwindow id=d15540e2465 href="http://dx.doi.org/10.3978/j.issn.2072-1439.2014.01.15">Publisher Full Text </a> | <a target=xrefwindow id=d15540e2469 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3944183">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/728494276">F1000 Recommendation</a></span></li><li><a name=ref-49 class=n-a></a><span class=label>49. </span>&nbsp;<span class=citation><a name=d15540e2482 class=n-a></a>Sugimoto R, Nakao A, Yamane M, <i> et al.</i>: Sirolimus amelioration of clinical symptoms of recurrent lymphangioleiomyomatosis after living-donor lobar lung transplantation. <i>J Heart Lung Transplant.</i> 2008; <b>27</b>(8): 921–4. <a target=xrefwindow id=d15540e2493 href="http://www.ncbi.nlm.nih.gov/pubmed/18656809">PubMed Abstract </a> | <a target=xrefwindow id=d15540e2496 href="http://dx.doi.org/10.1016/j.healun.2008.05.012">Publisher Full Text </a></span></li><li><a name=ref-50 class=n-a></a><span class=label>50. </span>&nbsp;<span class=citation><a name=d15540e2505 class=n-a></a>Ohara T, Oto T, Miyoshi K, <i> et al.</i>: Sirolimus ameliorated post lung transplant chylothorax in lymphangioleiomyomatosis. <i>Ann Thorac Surg.</i> 2008; <b>86</b>(6): e7–8. <a target=xrefwindow id=d15540e2516 href="http://www.ncbi.nlm.nih.gov/pubmed/19021963">PubMed Abstract </a> | <a target=xrefwindow id=d15540e2519 href="http://dx.doi.org/10.1016/j.athoracsur.2008.07.062">Publisher Full Text </a></span></li><li><a name=ref-51 class=n-a></a><span class=label>51. </span>&nbsp;<span class=citation><a name=d15540e2528 class=n-a></a>Barrera P, Simons SO, Luijk B, <i> et al.</i>: Efficacy of sirolimus therapy for chylous effusions in lymphangioleiomyomatosis. <i>Ann Am Thorac Soc.</i> 2013; <b>10</b>(4): 408–9. <a target=xrefwindow id=d15540e2539 href="http://www.ncbi.nlm.nih.gov/pubmed/23952870">PubMed Abstract </a> | <a target=xrefwindow id=d15540e2542 href="http://dx.doi.org/10.1513/AnnalsATS.201212-125OC">Publisher Full Text </a></span></li><li><a name=ref-52 class=n-a></a><span class=label>52. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/730613921"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d15540e2551 class=n-a></a>Lama A, Ferreiro L, Golpe A, <i> et al.</i>: Characteristics of Patients with Lymphangioleiomyomatosis and Pleural Effusion: A Systematic Review. <i>Respiration.</i> 2016; <b>91</b>(3): 256–64. <a target=xrefwindow id=d15540e2562 href="http://www.ncbi.nlm.nih.gov/pubmed/26938102">PubMed Abstract </a> | <a target=xrefwindow id=d15540e2565 href="http://dx.doi.org/10.1159/000444264">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/730613921">F1000 Recommendation</a></span></li><li><a name=ref-53 class=n-a></a><span class=label>53. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/717976446"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d15540e2578 class=n-a></a>Bissler JJ, Kingswood JC, Radzikowska E, <i> et al.</i>: Everolimus for angiomyolipoma associated with tuberous sclerosis complex or sporadic lymphangioleiomyomatosis (EXIST-2): a multicentre, randomised, double-blind, placebo-controlled trial. <i>Lancet.</i> 2013; <b>381</b>(9869): 817–24. <a target=xrefwindow id=d15540e2589 href="http://www.ncbi.nlm.nih.gov/pubmed/23312829">PubMed Abstract </a> | <a target=xrefwindow id=d15540e2592 href="http://dx.doi.org/10.1016/S0140-6736(12)61767-X">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/717976446">F1000 Recommendation</a></span></li><li><a name=ref-54 class=n-a></a><span class=label>54. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/728367152"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d15540e2606 class=n-a></a>Bissler JJ, Kingswood JC, Radzikowska E, <i> et al.</i>: Everolimus long-term use in patients with tuberous sclerosis complex: Four-year update of the EXIST-2 study. <i>PLoS One.</i> 2017; <b>12</b>(8): e0180939. <a target=xrefwindow id=d15540e2617 href="http://www.ncbi.nlm.nih.gov/pubmed/28792952">PubMed Abstract </a> | <a target=xrefwindow id=d15540e2620 href="http://dx.doi.org/10.1371/journal.pone.0180939">Publisher Full Text </a> | <a target=xrefwindow id=d15540e2624 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5549893">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/728367152">F1000 Recommendation</a></span></li><li><a name=ref-55 class=n-a></a><span class=label>55. </span>&nbsp;<span class=citation><a name=d15540e2637 class=n-a></a>Taveira-DaSilva AM, Hathaway OM, Sachdev V, <i> et al.</i>: Pulmonary artery pressure in lymphangioleiomyomatosis: an echocardiographic study. <i>Chest.</i> 2007; <b>132</b>(5): 1573–8. <a target=xrefwindow id=d15540e2648 href="http://www.ncbi.nlm.nih.gov/pubmed/17890459">PubMed Abstract </a> | <a target=xrefwindow id=d15540e2651 href="http://dx.doi.org/10.1378/chest.07-1205">Publisher Full Text </a> | <a target=xrefwindow id=d15540e2655 href="http://www.ncbi.nlm.nih.gov/pmc/articles/2946895">Free Full Text </a></span></li><li><a name=ref-56 class=n-a></a><span class=label>56. </span>&nbsp;<span class=citation><a name=d15540e2664 class=n-a></a>Cottin V, Harari S, Humbert M, <i> et al.</i>: Pulmonary hypertension in lymphangioleiomyomatosis: characteristics in 20 patients. <i>Eur Respir J.</i> 2012; <b>40</b>(3): 630–40. <a target=xrefwindow id=d15540e2675 href="http://www.ncbi.nlm.nih.gov/pubmed/22362861">PubMed Abstract </a> | <a target=xrefwindow id=d15540e2678 href="http://dx.doi.org/10.1183/09031936.00093111">Publisher Full Text </a></span></li><li><a name=ref-57 class=n-a></a><span class=label>57. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727542026"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d15540e2687 class=n-a></a>Freitas CSG, Baldi BG, Jardim C, <i> et al.</i>: Pulmonary hypertension in lymphangioleiomyomatosis: prevalence, severity and the role of carbon monoxide diffusion capacity as a screening method. <i>Orphanet J Rare Dis.</i> 2017; <b>12</b>(1): 74. <a target=xrefwindow id=d15540e2698 href="http://www.ncbi.nlm.nih.gov/pubmed/28427470">PubMed Abstract </a> | <a target=xrefwindow id=d15540e2701 href="http://dx.doi.org/10.1186/s13023-017-0626-0">Publisher Full Text </a> | <a target=xrefwindow id=d15540e2705 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5399314">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727542026">F1000 Recommendation</a></span></li><li><a name=ref-58 class=n-a></a><span class=label>58. </span>&nbsp;<span class=citation><a name=d15540e2718 class=n-a></a>Wu X, Xu W, Wang J, <i> et al.</i>: Clinical characteristics in lymphangioleiomyomatosis-related pulmonary hypertension: an observation on 50 patients. <i>Front Med.</i> 2018. <a target=xrefwindow id=d15540e2726 href="http://www.ncbi.nlm.nih.gov/pubmed/29675687">PubMed Abstract </a> | <a target=xrefwindow id=d15540e2729 href="http://dx.doi.org/10.1007/s11684-018-0634-z">Publisher Full Text </a></span></li><li><a name=ref-59 class=n-a></a><span class=label>59. </span>&nbsp;<span class=citation><a name=d15540e2738 class=n-a></a>Pollock-BarZiv S, Cohen MM, Downey GP, <i> et al.</i>: Air travel in women with lymphangioleiomyomatosis. <i>Thorax.</i> 2007; <b>62</b>(2): 176–80. <a target=xrefwindow id=d15540e2749 href="http://www.ncbi.nlm.nih.gov/pubmed/17040934">PubMed Abstract </a> | <a target=xrefwindow id=d15540e2752 href="http://dx.doi.org/10.1136/thx.2006.058537">Publisher Full Text </a> | <a target=xrefwindow id=d15540e2756 href="http://www.ncbi.nlm.nih.gov/pmc/articles/2111263">Free Full Text </a></span></li><li><a name=ref-60 class=n-a></a><span class=label>60. </span>&nbsp;<span class=citation><a name=d15540e2766 class=n-a></a>Taveira-DaSilva AM, Burstein D, Hathaway OM, <i> et al.</i>: Pneumothorax after air travel in lymphangioleiomyomatosis, idiopathic pulmonary fibrosis, and sarcoidosis. <i>Chest.</i> 2009; <b>136</b>(3): 665–70. <a target=xrefwindow id=d15540e2777 href="http://www.ncbi.nlm.nih.gov/pubmed/19318672">PubMed Abstract </a> | <a target=xrefwindow id=d15540e2780 href="http://dx.doi.org/10.1378/chest.08-3034">Publisher Full Text </a> | <a target=xrefwindow id=d15540e2784 href="http://www.ncbi.nlm.nih.gov/pmc/articles/2775992">Free Full Text </a></span></li><li><a name=ref-61 class=n-a></a><span class=label>61. </span>&nbsp;<span class=citation><a name=d15540e2793 class=n-a></a>Hu X, Cowl CT, Baqir M, <i> et al.</i>: Air travel and pneumothorax. <i>Chest.</i> 2014; <b>145</b>(4): 688–94. <a target=xrefwindow id=d15540e2804 href="http://www.ncbi.nlm.nih.gov/pubmed/24687705">PubMed Abstract </a> | <a target=xrefwindow id=d15540e2807 href="http://dx.doi.org/10.1378/chest.13-2363">Publisher Full Text </a></span></li><li><a name=ref-62 class=n-a></a><span class=label>62. </span>&nbsp;<span class=citation><a name=d15540e2816 class=n-a></a>Johnson SR, Tattersfield AE, <i> et al.</i>: Clinical experience of lymphangioleiomyomatosis in the UK. <i>Thorax.</i> 2000; <b>55</b>(12): 1052–7. <a target=xrefwindow id=d15540e2827 href="http://www.ncbi.nlm.nih.gov/pubmed/11083892">PubMed Abstract </a> | <a target=xrefwindow id=d15540e2830 href="http://dx.doi.org/10.1136/thorax.55.12.1052">Publisher Full Text </a> | <a target=xrefwindow id=d15540e2834 href="http://www.ncbi.nlm.nih.gov/pmc/articles/1745654">Free Full Text </a></span></li><li><a name=ref-63 class=n-a></a><span class=label>63. </span>&nbsp;<span class=citation><a name=d15540e2843 class=n-a></a>Cohen MM, Freyer AM, Johnson SR: Pregnancy experiences among women with lymphangioleiomyomatosis. <i>Respir Med.</i> 2009; <b>103</b>(5): 766–72. <a target=xrefwindow id=d15540e2851 href="http://www.ncbi.nlm.nih.gov/pubmed/19117742">PubMed Abstract </a> | <a target=xrefwindow id=d15540e2854 href="http://dx.doi.org/10.1016/j.rmed.2008.11.007">Publisher Full Text </a></span></li><li><a name=ref-64 class=n-a></a><span class=label>64. </span>&nbsp;<span class=citation><a name=d15540e2863 class=n-a></a>Henske EP, McCormack FX: Lymphangioleiomyomatosis - a wolf in sheep's clothing. <i>J Clin Invest.</i> 2012; <b>122</b>(11): 3807–16. <a target=xrefwindow id=d15540e2871 href="http://www.ncbi.nlm.nih.gov/pubmed/23114603">PubMed Abstract </a> | <a target=xrefwindow id=d15540e2874 href="http://dx.doi.org/10.1172/JCI58709">Publisher Full Text </a> | <a target=xrefwindow id=d15540e2877 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3484429">Free Full Text </a></span></li></ul></div></div></div> </div> <div id=article-comments class="article-comments padding-bottom-20"> <div class=current-article-comment-section> <h2 class=main-title name=add-new-comment id=add-new-comment> <span class="research-layout f1r-article-mobile-inline valign-middle"> <span class="f1r-icon icon-104_comments size30"></span> </span> <span class=f1r-article-desk-inline>Comments on this article</span> <span class=f1r-article-mobile-inline>Comments (0)</span> <span class="f1r-article-mobile-inline float-right"> <span class="f1r-icon icon-14_more_small"></span> <span class="f1r-icon icon-10_less_small"></span> </span> </h2> </div> <div class="f1r-article-desk-inline referee-report-info-box referee-report-version-box"> Version 1 </div> <div class="f1r-article-mobile research-layout mobile-version-info padding-top-30"> <span class=mversion>VERSION 1</span> <span class=details>PUBLISHED 18 Jun 2018</span> <span class="article-pubinfo-mobile versions-section"> </span> </div> <div class="f1r-article-mobile research-layout margin-top-20 is-centered"> <a href="/login?originalPath=/articles/7-758/v1&scrollTo=add-new-comment" class=register-report-comment-button data-test-id=add-comment_mob> <button class="primary orange extra-padding comment-on-this-report">ADD YOUR COMMENT</button> </a> </div> <a href="/login?originalPath=/articles/7-758/v1&scrollTo=add-new-comment" class="f1r-article-desk register-report-comment-button" data-test-id=add-comment> <span class=contracted></span>Comment </a> </div> <div class="f1r-article-mobile margin-bottom-30"> <div class=contracted-details> <a href="#" class="contracted-details-label author-affiliations"><span class=contracted></span>Author details</a> <a href="#" class=section-title>Author details</a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details affiliations is-hidden"> <sup>1</sup> Department of Respiratory Medicine, Peking Union Medical College Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing , China<br/> <sup>2</sup> Division of Pulmonary and Critical Care Medicine, Mayo Clinic , Rochester, MN, USA<br/> <p> <div class=margin-bottom> Kai-Feng Xu <br/> <span>Roles: </span> Conceptualization, Methodology, Project Administration, Validation, Visualization, Writing – Original Draft Preparation, Writing – Review & Editing </div> <div class=margin-bottom> Xinlun Tian <br/> <span>Roles: </span> Conceptualization, Project Administration, Visualization, Writing – Original Draft Preparation, Writing – Review & Editing </div> <div class=margin-bottom> Jay H Ryu <br/> <span>Roles: </span> Conceptualization, Methodology, Project Administration, Supervision, Validation, Visualization, Writing – Review & Editing </div> </p> </div> </div> <div class=contracted-details> <a href="#" class=section-title>Article Versions (1)</a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details grant-information article-page is-hidden"> <div> <a href="https://f1000research.com/articles/7-758/v1" title="Open version 1 of this article." class="" gahelper=1>version 1</a> <span class="article-pubinfo-mobile versions-section"> </span> </div> <div> Published: 18 Jun 2018, 7:758 </div> <div class=""><a href="https://doi.org/10.12688/f1000research.14564.1">https://doi.org/10.12688/f1000research.14564.1</a></div> </div> </div> <div class=contracted-details> <a href="#" class=section-title> <span class="f1r-icon icon-100_open_access"></span> Copyright </a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details grant-information article-page is-hidden"> © 2018 Xu KF <em>et al</em>. This is an open access article distributed under the terms of the <a href="http://creativecommons.org/licenses/by/4.0/" target=_blank data-test-id=box-licence-link>Creative Commons Attribution License</a>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. </div> </div> <div class="padding-top-30 research-layout"> <div class=article-toolbox-wrapper-mobile> <div class=article-tools-icon-mobile data-section=download> <span class="f1r-icon icon-76_download_file white"></span> </div> <div class="article-tools-icon-mobile mobile-metrics article-metrics-wrapper metrics-icon-wrapper" data-section=metrics data-version-id=15851 data-id=14564 data-downloads="" data-views="" data-scholar="10.12688/f1000research.14564.1" data-recommended="" data-f1r-ga-helper="Article Page Metrics (Mobile)"> <span class="f1r-icon icon-89_metrics white"></span> </div> <div class=article-tools-divider-mobile></div> <div class=article-tools-icon-mobile data-section=cite> <span class="f1r-icon icon-82_quote white"></span> </div> <div class="article-tools-icon-mobile " data-section=track> <span class="f1r-icon icon-90_track white"></span> </div> <div class=article-tools-divider-mobile></div> <div class=article-tools-icon-mobile data-section=share> <span class="f1r-icon icon-34_share white"></span> </div> <span class=article-toolbox-stretch></span> </div> <div class=article-toolbox-content-mobile> <div class="toolbox-section download"> <div class=toolbox-section-heading>Download</div> <div class=toolbox-section-content> <a href="https://f1000research.com/articles/7-758/v1/pdf?article_uuid=ad2279cf-8dd6-4a13-b7e7-f948f36c01ec" title="Download PDF" class="no-decoration pdf-download-helper"> <span class="f1r-icon icon-102_download_pdf toolbox-section-icon"></span> </a> <div class=toolbox-section-option-divider>&nbsp;</div> <a id=mobile-download-xml class=no-decoration href="#" title="Download XML"> <span class="f1r-icon icon-103_download_xml toolbox-section-icon"></span> </a> </div> <div class=toolbox-section-divider></div> <div class=toolbox-section-heading>Export To</div> <div class=toolbox-section-content> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=WORKSPACE>Sciwheel</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=BIBTEX>Bibtex</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=ENDNOTE>EndNote</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=PROCITE>ProCite</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=REF_MANAGER>Ref. Manager (RIS)</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=SENTE>Sente</button> </div> </div> <div class="toolbox-section metrics"> <div class="toolbox-section-heading no-top-border">metrics</div> <div class="toolbox-section-divider toolbox-section-divider--no-height"></div> <div class=article-metrics-pageinfo> <div class=c-article-metrics-table> <table class=c-article-metrics-table__table> <thead> <tr> <th></th> <th><span class=c-article-metrics-table__heading>Views</span></th> <th><span class=c-article-metrics-table__heading>Downloads</span></th> </tr> </thead> <tbody> <tr> <th class=c-article-metrics-table__row-heading><span class="c-article-metrics-table__platform u-platform--" data-test-id=metrics_platform_name_mob>F1000Research</span></th> <td class="c-article-metrics-table__value js-article-views-count" data-test-id=metrics_platform_views_mob>-</td> <td class="c-article-metrics-table__value js-article-downloads-count" data-test-id=metrics_platform_downloads_mob>-</td> </tr> <tr> <th class=c-article-metrics-table__row-heading> <span class="u-ib u-middle c-article-metrics-table__pmc" data-test-id=metrics_pmc_name_mob>PubMed Central</span> <div class="c-block-tip c-block-tip--centered c-article-metrics-table__tooltip c-block-tip--md-padding c-block-tip--small-arrow u-ib u-middle"> <button type=button class="u-black--medium u-black--high@hover u-ib u-middle c-button--icon c-button--text c-block-tip__toggle"><i class="material-icons c-button--icon__icon">info_outline</i></button> <div class=c-block-tip__content>Data from PMC are received and updated monthly.</div> </div> </th> <td class="c-article-metrics-table__value js-pmc-views-count" data-test-id=metrics_pmc_views_mob>-</td> <td class="c-article-metrics-table__value js-pmc-downloads-count" data-test-id=metrics_pmc_downloads_mob>-</td> </tr> </tbody> </table> </div> </div> <span class=metrics-citations-container> <div class=toolbox-section-divider></div> <div class="toolbox-section-heading u-mb--1">Citations</div> <div> <div class=toolbox-section-colsplit> <div class=citations-scopus-logo> <a href="" target=_blank class="is-hidden metrics-citation-icon" title="View full citation details at www.scopus.com"><i class="material-icons scopus-icon">open_in_new</i></a> </div> <div class="toolbox-section-count scopus"> <a href='' class='scopus-citation-link is-hidden' target=_blank title='View full citation details at www.scopus.com'>0</a> </div> </div> <div class=toolbox-section-colsplit> <div class="citations-pubmed-logo f1000research"> <a href="" target=_blank class="is-hidden metrics-citation-icon f1000research" title="View full citation details"><i class="material-icons scopus-icon">open_in_new</i></a> </div> <div class="toolbox-section-count pubmed"> <a href='' class='pubmed-citation-link is-hidden' target=_blank title='View full citation details'>0</a> </div> </div> <div class=toolbox-section-divider></div> <div class=toolbox-section-content> <div class="citations-scholar-logo f1000research"> <a href="" target=_blank class="is-hidden metrics-citation-icon google-scholar f1000research" title="View full citation details" data-scholar="10.12688/f1000research.14564.1"><i class="material-icons scopus-icon">open_in_new</i></a> </div> </div> </div> </span> <span class=metrics-details-container> <div class=toolbox-section-divider></div> <div class="toolbox-section-content altmetric-section"> <div class=altmetrics-image></div> <div class=altmetrics-more-link> <a href="" target=_blank class=f1r-standard-link>SEE MORE DETAILS</a> </div> <div class=altmetric-mobile-column-counts></div> <div class=altmetric-mobile-column-readers></div> <div class=toolbox-section-divider></div> </div> </span> </div> <div class="toolbox-section cite"> <div class="toolbox-section-heading no-top-border">CITE</div> <div class=toolbox-section-divider></div> <div class=toolbox-section-heading>how to cite this article</div> <div id=citation-copy-mobile class="toolbox-section-content text-content heading9 small" data-test-id=mob_copy-citation_text> Xu KF, Tian X and Ryu JH. Recent advances in the management of lymphangioleiomyomatosis [version 1; peer review: 4 approved] <i>F1000Research</i> 2018, <b>7</b>(F1000 Faculty Rev):758 (<a href="https://doi.org/10.12688/f1000research.14564.1" target=_blank>https://doi.org/10.12688/f1000research.14564.1</a>) </div> <div class=toolbox-section-divider></div> <div class="toolbox-section-content text-content heading9 small"> NOTE: <em>it is important to ensure the information in <b>square brackets after the title</b> is included in all citations of this article.</em> </div> <div class=toolbox-section-content> <button class="primary orange extra-padding copy-cite-article-mobile js-clipboard" data-clipboard-target="#citation-copy-mobile" title="Copy the current citation details." data-test-id=mob_copy-citation_button-mob>COPY CITATION DETAILS</button> </div> </div> <div class="toolbox-section track"> <div class="toolbox-section-heading no-top-border">track</div> <div class=toolbox-section-divider></div> <div class=toolbox-section-heading>receive updates on this article</div> <div class="toolbox-section-content padding-left-20 padding-right-20 heading9 small"> Track an article to receive email alerts on any updates to this article. </div> <div class=toolbox-section-content> <a data-article-id=14564 id=mobile-track-article-signin-14564 title="Receive updates on new activity such as publication of new versions, peer reviews or author responses." href="/login?originalPath=/trackArticle/14564?target=/articles/7-758/v1"> <button class="primary orange extra-padding"> TRACK THIS ARTICLE </button> </a> </div> </div> <div class="toolbox-section share"> <div class="toolbox-section-heading no-top-border">Share</div> <div class=toolbox-section-divider></div> <div class=toolbox-section-content> <a target=_blank class="f1r-shares-icon-square f1r-shares-email" title="Email this article"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-twitter" title="Share on Twitter"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-facebook" title="Share on Facebook"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-linkedin" title="Share on LinkedIn"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-reddit" title="Share on Reddit"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-mendelay" title="Share on Mendeley"></a> <div class="email-article-wrapper email-article-version-container"> <div class=toolbox-section-divider></div> <script src='https://www.recaptcha.net/recaptcha/api.js'></script> <form class="recommend-version-form-mobile research-layout"> <p>All fields are required.</p> <input name=versionId type=hidden value=15851 /> <input name=articleId type=hidden value=14564 /> <input name=senderName class="form-input-field reg-form" value="" type=text placeholder="Your name"/> <input name=senderEmail class="form-input-field reg-form margin-top" value="" type=text placeholder="Your email address"/> <textarea name=recipientEmails class="form-textarea-field ninetynine-percent-wide margin-top no-resize" placeholder="Recipient email address(es) (comma delimited)"></textarea> <input class="form-input-field reg-form margin-top" name=subject type=text value="Interesting article on F1000Research" placeholder=Subject /> <textarea name=message class="form-textarea-field reg-form margin-top no-resize">I thought this article from F1000Research (https://f1000research.com) would be of interest to you.</textarea> <div class="g-recaptcha margin-top" data-sitekey=6LcHqxoUAAAAANP3_0TzpGG6qFvl4DhbUcuRzw7W></div> <input value="" name=captcha type=hidden /> <p>A full article citation will be automatically included.</p> <p><img class="ticker-email-article-details hidden" src="/img/ticker.gif" alt=loading /></p> <button class="secondary orange margin-bottom" data-test-id=version_share_email_send>SEND EMAIL</button> <div class="orange-message margin-bottom is-hidden" data-test-id=version_share_email_message></div> </form> </div> </div> </div> </div> </div> <a name=article-reports></a> <div id=article-reports class="u-mt--3 reports-comments no-divider"> <div class="current-referee-status current-referee-status--faculty "> <h2 class=main-title id=current-referee-status> <span class="research-layout f1r-article-mobile-inline valign-middle"> <span class="f1r-icon icon-85_peer_review size30"></span> </span> Open Peer Review <span class="f1r-article-mobile-inline float-right"> <span class="f1r-icon icon-14_more_small"></span> <span class="f1r-icon icon-10_less_small"></span> </span> </h2> <a name=current-referee-status></a> <div class=current-referee-status__content name=add-new-report-comment id=add-new-report-comment> Current Reviewer Status: <span class="research-layout f1r-article-desk-inline"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-mobile float-right"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-desk-inline"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-mobile float-right"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-desk-inline"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-mobile float-right"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-desk-inline"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-mobile float-right"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-mobile"> <div class=mobile-ref-status-help> Key to Reviewer Statuses <span class=referee-status-pointer></span> <span class="view-control float-right">VIEW</span> <span class="view-control float-right is-hidden">HIDE</span> <div class=mobile-ref-status-help-content> <div class="cf margin-top"> <span class="f1r-icon icon-86_approved status-green smaller float-left margin-bottom-40 margin-right" title=Approved></span> <span class=title>Approved</span>The paper is scientifically sound in its current form and only minor, if any, improvements are suggested </div> <div class="cf margin-top"> <span class="f1r-icon icon-87_approved_reservations status-green smaller float-left margin-bottom-40 margin-right" title="Approved with Reservations"></span> <span class=title>Approved with reservations</span> A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit. </div> <div class="cf margin-top"> <span class="f1r-icon icon-88_not_approved status-red small float-left margin-bottom-30 margin-right" title="Not Approved"></span> <span class=title>Not approved</span>Fundamental flaws in the paper seriously undermine the findings and conclusions </div> </div> </div> </span> <div class=editorial-note> <h5 class=editorial-note__title>Editorial Note on the Review Process</h5> <p class=editorial-note__text><a href="/browse/faculty-reviews">Faculty Reviews</a> are review articles written by the prestigious Members of <a href="https://facultyopinions.com/prime/home">Faculty Opinions</a>. The articles are commissioned and peer reviewed before publication to ensure that the final, published version is comprehensive and accessible. The reviewers who approved the final version are listed with their names and affiliations.</p> </div> <div class=approved-referee> <h4 class=approved-referee__title>Reviewers who approved this article</h4> <ol class=approved-referee__list> <li class="approved-referee__list-item "> <span class=approved-referee__co-referee> <strong>Srihari Veeraraghavan</strong>, Division of Pulmonary, Allergy and Critical Care, Emory University School of Medicine, USA </span> <span class=approved-referee__competing-list> <strong>Competing interests:</strong> No competing interests were declared. (for version 1) <br> </span> </li> <li class="approved-referee__list-item margin-top-20"> <span class=approved-referee__co-referee> <strong>Adrian Shifren</strong>, Department of Internal Medicine, Washington University School of Medicine, USA </span> <span class=approved-referee__competing-list> <strong>Competing interests:</strong> No competing interests were declared. (for version 1) <br> </span> </li> <li class="approved-referee__list-item margin-top-20"> <span class=approved-referee__co-referee> <strong>David Neal Franz</strong>, Cincinnati Children's Hospital Medical Center, USA </span> <span class=approved-referee__competing-list> <strong>Competing interests:</strong> No competing interests were declared. (for version 1) <br> </span> </li> <li class="approved-referee__list-item margin-top-20"> <span class=approved-referee__co-referee> <strong>Nabeel Hamzeh</strong>, Department of Internal Medicine, University of Iowa, USA </span> <span class=approved-referee__competing-list> <strong>Competing interests:</strong> No competing interests were declared. (for version 1) <br> </span> </li> </ol> </div> </div> </div> </div> <div class="f1r-article-mobile research-layout"> <div class="mobile-sections-divider before-comments"></div> </div> <div id=article-comments class="article-comments padding-bottom-20"> <div class=current-article-comment-section> <h2 class=main-title name=add-new-comment id=add-new-comment> <span class="research-layout f1r-article-mobile-inline valign-middle"> <span class="f1r-icon icon-104_comments size30"></span> </span> <span class=f1r-article-desk-inline>Comments on this article</span> <span class=f1r-article-mobile-inline>Comments (0)</span> <span class="f1r-article-mobile-inline float-right"> <span class="f1r-icon icon-14_more_small"></span> <span class="f1r-icon icon-10_less_small"></span> </span> </h2> </div> <div class="f1r-article-desk-inline referee-report-info-box referee-report-version-box"> Version 1 </div> <div class="f1r-article-mobile research-layout mobile-version-info padding-top-30"> <span class=mversion>VERSION 1</span> <span class=details>PUBLISHED 18 Jun 2018</span> <span class="article-pubinfo-mobile versions-section"> </span> </div> <div class="f1r-article-mobile research-layout margin-top-20 is-centered"> <a href="/login?originalPath=/articles/7-758/v1&scrollTo=add-new-comment" class=register-report-comment-button data-test-id=add-comment_mob> <button class="primary orange extra-padding comment-on-this-report">ADD YOUR COMMENT</button> </a> </div> <a href="/login?originalPath=/articles/7-758/v1&scrollTo=add-new-comment" class="f1r-article-desk register-report-comment-button" data-test-id=add-comment> <span class=contracted></span>Comment </a> </div> </div> </div> <div id=article_main-column class="p-article__sidebar o-layout__item u-1/3 not-expanded js-article-sidebar"> <div class="o-tab p-article__column-toggle-container"> <button class="c-tab c-tab--left js-column-toggle p-article__column-toggle not-expanded " type=button data-target-main=article_main-column data-target-secondary=article_secondary-column><i class="c-tab__icon material-icons u-hide@expanded">keyboard_arrow_left</i><i class="c-tab__icon material-icons u-show@expanded">keyboard_arrow_right</i></button> </div> <div class=p-article__sidebar-content> <div class="p-article__sidebar-scroller js-article-sidebar-scroller"> <section class="p-article__sidebar-view js-article-sidebar-view js-article-sidebar-main u-pt u-pb--8" data-view=peer-review> <div class="o-layout o-layout--flush"> <div class="o-layout__item u-pl"> <h3 class="u-mt--0 u-mb--2 t-h3 u-weight--md u-pl" data-test-id=article_sidebar_heading>Open Peer Review</h3> </div> <div class=o-layout__item> <section class=""> <div class="p-article__sidebar-highlight u-mb--2 u-pr--1"> <div class="o-actions o-actions--middle"> <div class=o-actions__primary> <h4 class="u-mt--0 u-mb--0 u-ib u-middle t-h4 u-weight--md u-mr--1/2">Reviewer Status</h4> <div class="c-referee-status__icons u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--approved " title=Approved #data-refInfo=35411-34947></i> <i class="c-icn--f1r-icon c-icn--approved " title=Approved #data-refInfo=35410-34950></i> <i class="c-icn--f1r-icon c-icn--approved " title=Approved #data-refInfo=35413-34948></i> <i class="c-icn--f1r-icon c-icn--approved " title=Approved #data-refInfo=35412-34949></i> </div> </div> <div class="o-actions__secondary _mdl-layout"> <div class="c-block-tip p-article__sidebar-tooltip c-block-tip--below c-block-tip--small-arrow c-block-tip--sm-padding"> <button type=button class="c-button c-button--icon c-button--text c-block-tip__toggle"><i class="material-icons c-button--icon__icon">info_outline</i></button> <div class=c-block-tip__content> <p class="t-body u-mt--0 u-mb--0"><em class=u-weight--md>Alongside their report, reviewers assign a status to the article:</em></p> <dl class=c-definitions> <dt class="c-definitions__term u-upper t-control u-weight--md u-black--high"><span class="u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--approved " title=Approved #data-refInfo=""></i> </span> <span class="u-middle u-ib u-ml--1/2">Approved</span></dt> <dd class="c-definitions__description t-caption">The paper is scientifically sound in its current form and only minor, if any, improvements are suggested</dd> <dt class="c-definitions__term u-upper t-control u-weight--md u-black--high"><span class="u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--reservations" title="Approved with Reservations" #data-refInfo=""></i> </span> <span class="u-middle u-ib u-ml--1/2">Approved with reservations</span></dt> <dd class="c-definitions__description t-caption"> A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit. </dd> <dt class="c-definitions__term u-upper t-control u-weight--md u-black--high"><span class="u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--not-approved " title="Not Approved" #data-refInfo=""></i> </span> <span class="u-middle u-ib u-ml--1/2">Not approved</span></dt> <dd class="c-definitions__description t-caption">Fundamental flaws in the paper seriously undermine the findings and conclusions</dd> </dl> </div> </div> </div> </div> </div> <div class="o-layout__item u-mb--1"><h4 class="u-mt--0 u-mb--0 u-ib u-middle t-h4 u-weight--md">Reviewer Reports</h4></div> <table class="c-report-timeline u-mb--2"> <thead class=c-report-timeline__headings> <tr> <th></th> <th class="u-pb--1/2" colspan=4><em class="t-body u-weight--rg">Invited Reviewers</em></th> </tr> <tr class=c-report-timeline__headings-row> <th></th> <th class="c-report-timeline__headings-version p-article__color--dark">1</th> <th class="c-report-timeline__headings-version p-article__color--dark">2</th> <th class="c-report-timeline__headings-version p-article__color--dark">3</th> <th class="c-report-timeline__headings-version p-article__color--dark">4</th> </tr> </thead> <tbody> <tr class="c-report-timeline__row c-report-timeline__row--selected "> <th class=c-report-timeline__version> <a data-test-id=sidebar_timeline_v1_version href="https://f1000research.com/articles/7-758/v1">Version 1</a><br/> <span class=p-article__color--dark> <span data-test-id=sidebar_timeline_v1_date class=c-report-timeline__date>18 Jun 18</span> </span> </th> <td class="c-report-timeline__report c-report-timeline__cell "> <i class="c-icn--f1r-icon c-icn--approved small" title=Approved #data-refInfo=""></i> </td> <td class="c-report-timeline__report c-report-timeline__cell "> <i class="c-icn--f1r-icon c-icn--approved small" title=Approved #data-refInfo=""></i> </td> <td class="c-report-timeline__report c-report-timeline__cell "> <i class="c-icn--f1r-icon c-icn--approved small" title=Approved #data-refInfo=""></i> </td> <td class="c-report-timeline__report c-report-timeline__cell "> <i class="c-icn--f1r-icon c-icn--approved small" title=Approved #data-refInfo=""></i> </td> </tr> </tbody> </table> <div class=o-layout__item> <hr class="c-hr c-hr--low u-mb--2"> </div> </section> </div> <div class=o-layout__item> <div class="u-pl u-pr"> <p class="t-body u-mt--0 u-mb--2"><a href="/browse/faculty-reviews">Faculty Reviews</a> are review articles written by the prestigious Members of <a href="https://facultyopinions.com/prime/home" target=_blank class=in-text-link>Faculty Opinions</a>. The articles are commissioned and peer reviewed before publication to ensure that the final, published version is comprehensive and accessible. The reviewers who approved the final version are listed with their names and affiliations.</p> <ol class="p-article__faculty-referee-list t-caption"> <li> <p class=" u-mt--0 u-mb--1/2"><strong>Srihari Veeraraghavan</strong>, Division of Pulmonary, Allergy and Critical Care, Emory University School of Medicine, USA </p> <div class="c-read-more js-read-more " data-lines=3> <div class="c-read-more__content js-read-more-content "> <p class="u-mt--0 u-mb--0 p-article__color--light"> <strong class=u-weight--md>Competing interests:</strong> No competing interests were declared. </p> </div> <a href="#" class="c-read-more__toggle js-read-more-toggle t-caption"> <span class=c-read-more__expand>View more</span> <span class=c-read-more__contract>View less</span> </a> </div> </li> <li> <p class=" u-mt--0 u-mb--1/2"><strong>Adrian Shifren</strong>, Department of Internal Medicine, Washington University School of Medicine, USA </p> <div class="c-read-more js-read-more " data-lines=3> <div class="c-read-more__content js-read-more-content "> <p class="u-mt--0 u-mb--0 p-article__color--light"> <strong class=u-weight--md>Competing interests:</strong> No competing interests were declared. </p> </div> <a href="#" class="c-read-more__toggle js-read-more-toggle t-caption"> <span class=c-read-more__expand>View more</span> <span class=c-read-more__contract>View less</span> </a> </div> </li> <li> <p class=" u-mt--0 u-mb--1/2"><strong>David Neal Franz</strong>, Cincinnati Children's Hospital Medical Center, USA </p> <div class="c-read-more js-read-more " data-lines=3> <div class="c-read-more__content js-read-more-content "> <p class="u-mt--0 u-mb--0 p-article__color--light"> <strong class=u-weight--md>Competing interests:</strong> No competing interests were declared. </p> </div> <a href="#" class="c-read-more__toggle js-read-more-toggle t-caption"> <span class=c-read-more__expand>View more</span> <span class=c-read-more__contract>View less</span> </a> </div> </li> <li> <p class=" u-mt--0 u-mb--1/2"><strong>Nabeel Hamzeh</strong>, Department of Internal Medicine, University of Iowa, USA </p> <div class="c-read-more js-read-more " data-lines=3> <div class="c-read-more__content js-read-more-content "> <p class="u-mt--0 u-mb--0 p-article__color--light"> <strong class=u-weight--md>Competing interests:</strong> No competing interests were declared. </p> </div> <a href="#" class="c-read-more__toggle js-read-more-toggle t-caption"> <span class=c-read-more__expand>View more</span> <span class=c-read-more__contract>View less</span> </a> </div> </li> </ol> </div> </div> <section class="o-layout__item u-pl"> <div class=u-pl> <hr class="c-hr c-hr--low c-hr--md u-mb--3"> <h4 class="t-h3 u-weight--md u-mt--0 u-mb--2">Comments on this article</h4> <div class=u-mb--4> <p class="u-mt--0 u-mb--1 t-h4"><a class=p-article__color--light href="#article-comments">All Comments</a><span class=" u-ib u-ml--1/2 p-article__color--light">(0)</span></p> <a class=t-h4 href="/login?originalPath=/articles/7-758/v1&scrollTo=add-new-comment" data-test-id=add-comment>Add a comment</a> </div> <hr class="c-hr c-hr--low c-hr--md u-mb--4"> <div class="research-layout f1r-article-desk"> <div class="heading6 c-ribbon-wrapper c-ribbon-wrapper--etoc f1000research "> <div class=c-ribbon-wrapper__body>Sign up for content alerts</div> </div> </div> <div class="research-layout sidebar-sign-up-form f1r-article-desk u-mb--4 "> <form class=js-email-alert-signup action="#" method=POST data-email=tocAlertWeekly> <input type=hidden name=isUserLoggedIn class=js-email-alert-signup-logged-in value=N /> <input type=hidden name=userId class=js-email-alert-signup-user-id value=""/> <input type=hidden name=frequency class=js-email-alert-signup-frequency value=WEEKLY /> <div class="o-actions o-actions--middle"> <div class=o-actions__primary> <input type=email name=emailAddress class="form-input-field js-email-alert-signup-address u-1/1 u-bb" required=required placeholder=Email /> </div> <div class=o-actions__secondary> <div class="_mdl-layout u-ml--1/2"> <button class="mdl-button mdl-js-button mdl-button--colored mdl-button--small mdl-button--filled js-email-alert-signup-submit">Sign Up</button> </div> </div> </div> </form> <div id=sidebar-sign-up-message class="section-text js-email-alert-signup-msg is-hidden">You are now signed up to receive this alert</div> </div> <section class=js-terms-container> <hr class="c-hr c-hr--low c-hr--md u-mb--3"> <h4 class="t-h3 u-weight--md u-mt--0 u-mb--1">Browse by related subjects</h4> <div class="article-subcontainer article-subcontainer--sidebar"> <ul class=js-terms-list></ul> </div> </section> </div> </section> </div> </section> </div> <script src="/js/shared_scripts/modal-dialogue.js"></script> <script src="/js/shared_scripts/read-more.js"></script> <script src="/js/article/article-router.js"></script> <script src="/js/article/article-sidebar.js"></script> <script src="/js/referee/new/referee_helpers.js"></script> <script src="/js/article/article-column-toggle.js"></script> </div> </div> </div> </main> <input type=hidden id=_articleVersionUrl value="https://f1000research.com/articles/7-758/v1/"> <div class=research-help id=about-referee-status> <div class="research-layout research-help-content about-referee-status"> <span class="close-research-help dark-cross" title=Close></span> Alongside their report, reviewers assign a status to the article: <div class="cf research-help-row"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> <span class=research-help-text>Approved - the paper is scientifically sound in its current form and only minor, if any, improvements are suggested</span> </div> <div class="cf research-help-row"> <span class="f1r-icon icon-87_approved_reservations status-green smaller" title="Approved with Reservations"></span> <span class=research-help-text>Approved with reservations - A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit. </span> </div> <div class="cf research-help-row"> <span class="f1r-icon icon-88_not_approved status-red small" title="Not Approved"></span> <span class=research-help-text>Not approved - fundamental flaws in the paper seriously undermine the findings and conclusions</span> </div> </div> </div> <div id=datasets-info class=is-hidden> </div> <div class=article-interactive-content-container style="display: none;"> <a name=f-template class=n-a></a> <div class="interactive-content-wrapper padding-20"> <img src="" class=interactive-content-image title="Open the interactive image display"> <div class=interactive-content-title></div> <div class=interactive-content-text></div> <div class="f1r-article-desk interactive-content-ribbon" data-interactive-content-type=R-Script> <div class=interactive-content-label>Adjust parameters to alter display</div> <div class=interactive-content-button></div> </div> <div class="f1r-article-mobile mobile-interactive-note"> View on desktop for interactive features <img src="/img/icon/interactive_content.png" class="float-right margin-right-40"/> </div> <div class=clearfix></div> </div> </div> <div id=article-interactive-omero-container class=article-interactive-omero-container style="display: none;"> <div class=interactive-content-wrapper> <div class="interactive-omero-button omero-content" title="Open the interactive content window." data-interactive-content-type=Omero></div> <div class=has-interactive-content-image> <span class=box-arrow></span> <span class=box-middle>Includes Interactive Elements</span> <span class=box-end></span> </div> <div class="fig panel clearfix" style="margin: 0; padding-bottom: 20px;"> <a name=templatelink class=n-a></a> <a target=_blank href="" class=link-for-omero-image> <img src="" class=interactive-omero-image title="Open the image display window."> </a> <div class=caption> <div class=interactive-content-title></div> <div class=interactive-content-text></div> </div> <div class="is-hidden omero-image-list"></div> </div> <div class="f1r-article-mobile mobile-interactive-note omero"> View on desktop for interactive features <img src="/img/icon/interactive_content.png" class="float-right margin-right-40"/> </div> <div class=clearfix></div> </div> </div> <div class="add-comment-container shadow-box is-hidden" id=save-comment-container> <span id=save-comment-text class=intro-text>Edit comment</span> <textarea id=new-comment name=new-comment class="global-textarea comment margin-bottom margin-top"></textarea> <p><strong>Competing Interests</strong></p> <textarea id=new-competing-interests name=competing-interests class="global-textarea competing-interests margin-bottom check-xss"></textarea> <div class=clearfix></div> <button id=cancelComment type=button class="general-white-orange-button float-right no-background-button margin-left"> Cancel </button> <button id=save-comment-button commentId="" type=button class="general-white-orange-button float-right"> Save </button> <div class=clearfix></div> <div class="green-message margin-top is-hidden comment-is-saved">The comment has been saved.</div> <div class="red-message margin-top is-hidden comment-not-added">An error has occurred. Please try again.</div> <div class="red-message margin-top is-hidden comment-enter-text ucf">Your must enter a comment.</div> <div class="red-message margin-top is-hidden comment-references-error references">References error.</div> </div> <div class="modal-window-wrapper is-hidden"> <div id=conflicts-interests class="modal-window padding-20"> <div class=modal-window__content> <h2 class=h2-title>Competing Interests Policy</h2> <p> Provide sufficient details of any financial or non-financial competing interests to enable users to assess whether your comments might lead a reasonable person to question your impartiality. Consider the following examples, but note that this is not an exhaustive list: </p> <div class=heading5>Examples of 'Non-Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>Within the past 4 years, you have held joint grants, published or collaborated with any of the authors of the selected paper.</li> <li class=standard-padding>You have a close personal relationship (e.g. parent, spouse, sibling, or domestic partner) with any of the authors.</li> <li class=standard-padding>You are a close professional associate of any of the authors (e.g. scientific mentor, recent student).</li> <li class=standard-padding>You work at the same institute as any of the authors.</li> <li class=standard-padding>You hope/expect to benefit (e.g. favour or employment) as a result of your submission.</li> <li class=standard-padding>You are an Editor for the journal in which the article is published.</li> </ol> <div class="heading5 padding-top">Examples of 'Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>You expect to receive, or in the past 4 years have received, any of the following from any commercial organisation that may gain financially from your submission: a salary, fees, funding, reimbursements.</li> <li class=standard-padding>You expect to receive, or in the past 4 years have received, shared grant support or other funding with any of the authors.</li> <li class=standard-padding>You hold, or are currently applying for, any patents or significant stocks/shares relating to the subject matter of the paper you are commenting on.</li> </ol> </div> <div class="f1r-article-mobile research-layout"> <span class=modal-window-close-button></span> </div> </div> </div> <div class="o-modal c-email-alert-popup js-email-alert-popup is-hidden"> <div class="o-modal__body js-modal-body c-email-alert-popup__inner"> <h3 class=c-email-alert-popup__title>Stay Updated</h3> <p class=c-email-alert-popup__sub>Sign up for content alerts and receive a weekly or monthly email with all newly published articles</p> <p><a href="/register?originalPath=" class="c-email-alert-popup__lnk c-email-alert-popup__button js-email-alert-popup-action">Register with F1000Research</a></p> <p>Already registered? <a href="/login?originalPath=" class="c-email-alert-popup__lnk js-email-alert-popup-action">Sign in</a></p> <p class=c-email-alert-popup__footer><a class="c-email-alert-popup__lnk js-email-alert-popup-cancel" href="#">Not now, thanks</a></p> </div> </div> <div id=addCommentModal role=dialog aria-labelledby=addCommentModal_title aria-describedby=addCommentModal_description> <div class="c-modal js-modal is-closed p-article__add-comment-modal c-modal--xlarge js-article-comment-modal c-modal--scroll "> <aside class="c-modal__content u-black--high o-box u-pb--0 u-bg--2 c-modal--scroll-always "> <div class=c-modal__close> <button type=button class="c-button c-button--icon c-button--medium c-button--full@hover js-modal__close"><i class="c-button--icon__icon material-icons">close</i></button> </div> <div id=addCommentModal_description class="c-modal__description js-modal__content t-h4 u-mt--0 u-mb--2 u-black--medium"> <div class="js-add-comment-container t-caption u-black--high"> <div class=u-weight--bd>PLEASE NOTE</div> <div class=u-mt--1> <span class="red u-weight--bd">If you are an AUTHOR of this article,</span> please check that you signed in with the account associated with this article otherwise we cannot automatically identify your role as an author and your comment will be labelled as a &ldquo;User Comment&rdquo;. </div> <div class=u-mt--1> <span class="red u-weight--bd">If you are a REVIEWER of this article,</span> please check that you have signed in with the account associated with this article and then go to your <a href="/my/referee">account</a> to submit your report, please do not post your review here. </div> <div class="u-mt--1 u-mb--1"> If you do not have access to your original account, please <a href="mailto:research@f1000.com">contact us</a>. </div> <p class=no-top-margin>All commenters must hold a formal affiliation as per our <a href="/about/policies#commentspolicy" target=_blank>Policies</a>. The information that you give us will be displayed next to your comment.</p> <p>User comments must be in English, comprehensible and relevant to the article under discussion. We reserve the right to remove any comments that we consider to be inappropriate, offensive or otherwise in breach of the <a href="/about/legal/usercommenttermsandconditions" target=_blank>User Comment Terms and Conditions</a>. Commenters must not use a comment for personal attacks. When criticisms of the article are based on unpublished data, the data should be made available.</p> <div class="comments-note margin-bottom" id=accept-user-comments> <input class=js-add-comment-accept-terms type=checkbox id=acceptedTermsAndConditions name=acceptedTermsAndConditions> I accept the <a href="/about/legal/usercommenttermsandconditions" target=_blank> User Comment Terms and Conditions</a> <span class=required>&nbsp;</span> </div> <div class="default-error margin-top is-hidden comment-accept-conditions utac">Please confirm that you accept the User Comment Terms and Conditions.</div> <div class="research-layout registration-form u-mb--2"> <div class="u-mb--1 u-mt--2"> <strong>Affiliation</strong> </div> <div class=form-field> <input type=text name=institution class="form-input-field check-xss js-add-comment-institution" placeholder="Organization *" autocomplete=off /> <div class="default-error margin-top is-hidden comment-enter-institution institution">Please enter your organisation.</div> </div> <div class=form-field> <input type=text name=place class="form-input-field check-xss js-add-comment-place" placeholder=Place> </div> <div class=form-field> <div class="form-input-wrapper hundred-percent-wide"> <div class="new-select-standard-wrapper half-width inline-display heading10"> <select name=countryId id=country class="form-select-menu smaller js-add-comment-country"> <option value=-1>Country*</option> <option value=840>USA</option> <option value=826>UK</option> <option value=124>Canada</option> <option value=156>China</option> <option value=250>France</option> <option value=276>Germany</option> <optgroup label=-----------------------------------------------></optgroup> <option value=4>Afghanistan</option> <option value=248>Aland Islands</option> <option value=8>Albania</option> <option value=12>Algeria</option> <option value=16>American Samoa</option> <option value=20>Andorra</option> <option value=24>Angola</option> <option value=660>Anguilla</option> <option value=10>Antarctica</option> <option value=28>Antigua and Barbuda</option> <option value=32>Argentina</option> <option value=51>Armenia</option> <option value=533>Aruba</option> <option value=36>Australia</option> <option value=40>Austria</option> <option value=31>Azerbaijan</option> <option value=44>Bahamas</option> <option value=48>Bahrain</option> <option value=50>Bangladesh</option> <option value=52>Barbados</option> <option value=112>Belarus</option> <option value=56>Belgium</option> <option value=84>Belize</option> <option value=204>Benin</option> <option value=60>Bermuda</option> <option value=64>Bhutan</option> <option value=68>Bolivia</option> <option value=70>Bosnia and Herzegovina</option> <option value=72>Botswana</option> <option value=74>Bouvet Island</option> <option value=76>Brazil</option> <option value=86>British Indian Ocean Territory</option> <option value=92>British Virgin Islands</option> <option value=96>Brunei</option> <option value=100>Bulgaria</option> <option value=854>Burkina Faso</option> <option value=108>Burundi</option> <option value=116>Cambodia</option> <option value=120>Cameroon</option> <option value=124>Canada</option> <option value=132>Cape Verde</option> <option value=136>Cayman Islands</option> <option value=140>Central African Republic</option> <option value=148>Chad</option> <option value=152>Chile</option> <option value=156>China</option> <option value=162>Christmas Island</option> <option value=166>Cocos (Keeling) Islands</option> <option value=170>Colombia</option> <option value=174>Comoros</option> <option value=178>Congo</option> <option value=184>Cook Islands</option> <option value=188>Costa Rica</option> <option value=384>Cote d'Ivoire</option> <option value=191>Croatia</option> <option value=192>Cuba</option> <option value=196>Cyprus</option> <option value=203>Czech Republic</option> <option value=180>Democratic Republic of the Congo</option> <option value=208>Denmark</option> <option value=262>Djibouti</option> <option value=212>Dominica</option> <option value=214>Dominican Republic</option> <option value=218>Ecuador</option> <option value=818>Egypt</option> <option value=222>El Salvador</option> <option value=226>Equatorial Guinea</option> <option value=232>Eritrea</option> <option value=233>Estonia</option> <option value=231>Ethiopia</option> <option value=238>Falkland Islands</option> <option value=234>Faroe Islands</option> <option value=583>Federated States of Micronesia</option> <option value=242>Fiji</option> <option value=246>Finland</option> <option value=250>France</option> <option value=254>French Guiana</option> <option value=258>French Polynesia</option> <option value=260>French Southern Territories</option> <option value=266>Gabon</option> <option value=268>Georgia</option> <option value=276>Germany</option> <option value=288>Ghana</option> <option value=292>Gibraltar</option> <option value=300>Greece</option> <option value=304>Greenland</option> <option value=308>Grenada</option> <option value=312>Guadeloupe</option> <option value=316>Guam</option> <option value=320>Guatemala</option> <option value=831>Guernsey</option> <option value=324>Guinea</option> <option value=624>Guinea-Bissau</option> <option value=328>Guyana</option> <option value=332>Haiti</option> <option value=334>Heard Island and Mcdonald Islands</option> <option value=336>Holy See (Vatican City State)</option> <option value=340>Honduras</option> <option value=344>Hong Kong</option> <option value=348>Hungary</option> <option value=352>Iceland</option> <option value=356>India</option> <option value=360>Indonesia</option> <option value=364>Iran</option> <option value=368>Iraq</option> <option value=372>Ireland</option> <option value=376>Israel</option> <option value=380>Italy</option> <option value=388>Jamaica</option> <option value=392>Japan</option> <option value=832>Jersey</option> <option value=400>Jordan</option> <option value=398>Kazakhstan</option> <option value=404>Kenya</option> <option value=296>Kiribati</option> <option value=901>Kosovo (Serbia and Montenegro)</option> <option value=414>Kuwait</option> <option value=417>Kyrgyzstan</option> <option value=418>Lao People's Democratic Republic</option> <option value=428>Latvia</option> <option value=422>Lebanon</option> <option value=426>Lesotho</option> <option value=430>Liberia</option> <option value=434>Libya</option> <option value=438>Liechtenstein</option> <option value=440>Lithuania</option> <option value=442>Luxembourg</option> <option value=446>Macao</option> <option value=807>Macedonia</option> <option value=450>Madagascar</option> <option value=454>Malawi</option> <option value=458>Malaysia</option> <option value=462>Maldives</option> <option value=466>Mali</option> <option value=470>Malta</option> <option value=584>Marshall Islands</option> <option value=474>Martinique</option> <option value=478>Mauritania</option> <option value=480>Mauritius</option> <option value=175>Mayotte</option> <option value=484>Mexico</option> <option value=581>Minor Outlying Islands of the United States</option> <option value=498>Moldova</option> <option value=492>Monaco</option> <option value=496>Mongolia</option> <option value=499>Montenegro</option> <option value=500>Montserrat</option> <option value=504>Morocco</option> <option value=508>Mozambique</option> <option value=104>Myanmar</option> <option value=516>Namibia</option> <option value=520>Nauru</option> <option value=524>Nepal</option> <option value=530>Netherlands Antilles</option> <option value=540>New Caledonia</option> <option value=554>New Zealand</option> <option value=558>Nicaragua</option> <option value=562>Niger</option> <option value=566>Nigeria</option> <option value=570>Niue</option> <option value=574>Norfolk Island</option> <option value=580>Northern Mariana Islands</option> <option value=408>North Korea</option> <option value=578>Norway</option> <option value=512>Oman</option> <option value=586>Pakistan</option> <option value=585>Palau</option> <option value=275>Palestinian Territory</option> <option value=591>Panama</option> <option value=598>Papua New Guinea</option> <option value=600>Paraguay</option> <option value=604>Peru</option> <option value=608>Philippines</option> <option value=612>Pitcairn</option> <option value=616>Poland</option> <option value=620>Portugal</option> <option value=630>Puerto Rico</option> <option value=634>Qatar</option> <option value=638>Reunion</option> <option value=642>Romania</option> <option value=643>Russian Federation</option> <option value=646>Rwanda</option> <option value=654>Saint Helena</option> <option value=659>Saint Kitts and Nevis</option> <option value=662>Saint Lucia</option> <option value=666>Saint Pierre and Miquelon</option> <option value=670>Saint Vincent and the Grenadines</option> <option value=882>Samoa</option> <option value=674>San Marino</option> <option value=678>Sao Tome and Principe</option> <option value=682>Saudi Arabia</option> <option value=686>Senegal</option> <option value=688>Serbia</option> <option value=690>Seychelles</option> <option value=694>Sierra Leone</option> <option value=702>Singapore</option> <option value=703>Slovakia</option> <option value=705>Slovenia</option> <option value=90>Solomon Islands</option> <option value=706>Somalia</option> <option value=710>South Africa</option> <option value=239>South Georgia and the South Sandwich Is</option> <option value=410>South Korea</option> <option value=724>Spain</option> <option value=144>Sri Lanka</option> <option value=736>Sudan</option> <option value=740>Suriname</option> <option value=744>Svalbard and Jan Mayen</option> <option value=748>Swaziland</option> <option value=752>Sweden</option> <option value=756>Switzerland</option> <option value=760>Syria</option> <option value=158>Taiwan</option> <option value=762>Tajikistan</option> <option value=834>Tanzania</option> <option value=764>Thailand</option> <option value=270>The Gambia</option> <option value=528>The Netherlands</option> <option value=626>Timor-Leste</option> <option value=768>Togo</option> <option value=772>Tokelau</option> <option value=776>Tonga</option> <option value=780>Trinidad and Tobago</option> <option value=788>Tunisia</option> <option value=792>Turkey</option> <option value=795>Turkmenistan</option> <option value=796>Turks and Caicos Islands</option> <option value=798>Tuvalu</option> <option value=800>Uganda</option> <option value=826>UK</option> <option value=804>Ukraine</option> <option value=784>United Arab Emirates</option> <option value=850>United States Virgin Islands</option> <option value=858>Uruguay</option> <option value=840>USA</option> <option value=860>Uzbekistan</option> <option value=548>Vanuatu</option> <option value=862>Venezuela</option> <option value=704>Vietnam</option> <option value=876>Wallis and Futuna</option> <option value=905>West Bank and Gaza Strip</option> <option value=732>Western Sahara</option> <option value=887>Yemen</option> <option value=894>Zambia</option> <option value=716>Zimbabwe</option> </select> </div> </div> <div class="default-error margin-top is-hidden comment-enter-country country">Please select your country.</div> </div> </div> <textarea data-test-id=article_add-comment_comment name=new-comment class="js-add-comment-comment comment margin-bottom margin-top"></textarea> <div class="default-error margin-top comment-enter-text comment-error is-hidden ">You must enter a comment.</div> <label class="comments-note u-mt--2 u-mb--2" for=competingInterests_1> <div class="u-mb--1 u-mt--2"><strong data-test-id=article_report-add-comment_competing-interests-title>Competing Interests</strong></div> <p class="u-mb--2 u-mt--0" data-test-id=article_report-add-comment_competing-interests-description>Please disclose any <a href="#article-competing-intersts-policy" class=js-modal-competing-intersts-toggle>competing interests</a> that might be construed to influence your judgment of the article's or peer review report's validity or importance.</p> </label> <div id=article-competing-intersts-policy class=js-article-competing-interests-policy style="display: none;"> <h2 class="h2-title u-mt--0 u-pt--0">Competing Interests Policy</h2> <p> Provide sufficient details of any financial or non-financial competing interests to enable users to assess whether your comments might lead a reasonable person to question your impartiality. Consider the following examples, but note that this is not an exhaustive list: </p> <div class=heading5>Examples of 'Non-Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>Within the past 4 years, you have held joint grants, published or collaborated with any of the authors of the selected paper.</li> <li class=standard-padding>You have a close personal relationship (e.g. parent, spouse, sibling, or domestic partner) with any of the authors.</li> <li class=standard-padding>You are a close professional associate of any of the authors (e.g. scientific mentor, recent student).</li> <li class=standard-padding>You work at the same institute as any of the authors.</li> <li class=standard-padding>You hope/expect to benefit (e.g. favour or employment) as a result of your submission.</li> <li class=standard-padding>You are an Editor for the journal in which the article is published.</li> </ol> <div class="heading5 padding-top">Examples of 'Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>You expect to receive, or in the past 4 years have received, any of the following from any commercial organisation that may gain financially from your submission: a salary, fees, funding, reimbursements.</li> <li class=standard-padding>You expect to receive, or in the past 4 years have received, shared grant support or other funding with any of the authors.</li> <li class=standard-padding>You hold, or are currently applying for, any patents or significant stocks/shares relating to the subject matter of the paper you are commenting on.</li> </ol> </div> <div id=competingInterests_1 class="c-inline-editor js-inline-editor js-form_input u-bb--all u-mb--2 js-comment-competing-interests" data-name=competing-interests data-rows=3> <textarea id=competingInterests_1_input name=competing-interests placeholder="&nbsp;" required=false class="u-hide-visually js-inline-editor_input" tabindex=-1></textarea> <div class="c-inline-editor__editor js-inline-editor_editor o-box c-box o-box--tiny u-bg--11" data-target=competingInterests_1_input role=textbox required=false data-placeholder="&nbsp;" contenteditable=true></div> <span class="c-inline-editor__error js-inline-editor-message">Please state your competing interests</span> </div> <div data-test-id=article_add-comment_saved class="green-message comments is-hidden comment-is-saved">The comment has been saved.</div> <div data-test-id=article_add-comment_error class="default-error comments is-hidden comment-not-added">An error has occurred. Please try again.</div> <div class=clearfix></div> <div class=js-hook></div> </div> <div class="c-modal__extra-message js-modal__extra-message t-h4 u-black--medium"></div></div> <div class="c-modal__actions o-box__actions"> <a href="#" data-test-id=article_add-comment_cancel class="c-button c-button--full js-modal__close c-button--secondary">Cancel</a> <a href="#" data-test-id=article_add-comment_post class="c-button c-button--full js-modal__confirm c-button--primary">Post</a> </div> </aside> </div> </div> <style>
                .at-icon-wrapper {
        background-size: 100% !important;
    }
</style> <script src="/js/namespace.js"></script> <script src="/js/constants.js"></script> <script src="/js/utilities.js"></script> <script src="/js/article/alert-signup.js"></script> <script type='text/javascript'>
    var lTitle = "Recent advances in the management of lymphangioleiomyomatosis".replace("'", '');
    var linkedInUrl = "http://www.linkedin.com/shareArticle?url=https://f1000research.com/articles/7-758/v1" + "&title=" + encodeURIComponent(lTitle) + "&summary=" + encodeURIComponent('Read the article by ');

    var deliciousUrl = "https://del.icio.us/post?url=https://f1000research.com/articles/7-758/v1&title=" + encodeURIComponent(lTitle);

    var redditUrl = "http://reddit.com/submit?url=https://f1000research.com/articles/7-758/v1" + "&title=" + encodeURIComponent(lTitle);

            linkedInUrl += encodeURIComponent('Xu KF et al.');
    
    var offsetTop = /chrome/i.test( navigator.userAgent ) ? 4 : -10; 
    var addthis_config = {
            ui_offset_top: offsetTop,
                                    services_compact : "facebook,twitter,www.linkedin.com,www.mendeley.com,reddit.com",
            services_expanded : "facebook,twitter,www.linkedin.com,www.mendeley.com,reddit.com",
            services_custom : [
                {
                    name: "LinkedIn",
                    url:  linkedInUrl,
                    icon:"/img/icon/at_linkedin.svg"
                },
                {
                    name: "Mendeley",
                    url:  "http://www.mendeley.com/import/?url=https://f1000research.com/articles/7-758/v1/mendeley",
                    icon:"/img/icon/at_mendeley.svg"
                },
                {
                    name: "Reddit",
                    url:  redditUrl,
                    icon:"/img/icon/at_reddit.svg"
                },
            ]
        };


    var addthis_share = {
            url: "https://f1000research.com/articles/7-758",
            templates : {
                twitter : "Recent advances in the management of lymphangioleiomyomatosis. Xu KF et al., published by " + 
               "@F1000Research"
       + ", https://f1000research.com/articles/7-758/v1"
            }
        };

    if (typeof(addthis) != "undefined"){
        addthis.addEventListener('addthis.ready', checkCount);
        addthis.addEventListener('addthis.menu.share', checkCount);
    }

        $(".f1r-shares-twitter").attr("href", "https://twitter.com/intent/tweet?text=" + addthis_share.templates.twitter);
    $(".f1r-shares-facebook").attr("href", "https://www.facebook.com/sharer/sharer.php?u=" + addthis_share.url);
    $(".f1r-shares-linkedin").attr("href", addthis_config.services_custom[0].url);
    $(".f1r-shares-reddit").attr("href", addthis_config.services_custom[2].url);
    $(".f1r-shares-mendelay").attr("href", addthis_config.services_custom[1].url);

    function checkCount(){
        setTimeout(function(){
            $(".addthis_button_expanded").each(function(){
                var count = $(this).text();
                if (count !== "" && count != "0")
                    $(this).removeClass("is-hidden");
                else
                    $(this).addClass("is-hidden");
            });
        }, 1000);
    }
</script> <div id=citeReportModal role=dialog aria-labelledby=citeReportModal_title aria-describedby=citeReportModal_description> <div class="c-modal js-modal is-closed c-modal--large js-cite-report-modal "> <aside class="c-modal__content u-black--high o-box u-pb--0 u-black--high "> <div class=c-modal__close> <button type=button class="c-button c-button--icon c-button--medium c-button--full@hover js-modal__close"><i class="c-button--icon__icon material-icons">close</i></button> </div> <h1 id=citeReportModal_title class="c-modal__title t-h3 u-mt--0 u-mb--2 u-weight--md">How to cite this report</h1> <div id=citeReportModal_description class="c-modal__description js-modal__content t-h4 u-mt--0 u-mb--2 u-black--medium"> <div id="" class=js-report-citation-container>{{reportCitation}}</div> <div class="c-modal__extra-message js-modal__extra-message t-h4 u-black--medium"></div></div> <div class="c-modal__actions o-box__actions"> <a href="#" class="c-button c-button--full js-modal__close c-button--secondary">Cancel</a> <a href="#" title="Copy the current citation details to the clipboard." data-clipboard-target="#referee-report-citation" data-test-id=report_copy-citation_button class="c-button c-button--full js-modal__confirm c-button--primary js-clipboard c-mini-tooltip--above">Copy Citation Details</a> </div> </aside> </div> </div> <script src="/js/referee/new/referee_validators.js"></script> <script src="/js/referee/new/referee_helpers.js"></script> <script src="/js/referee/new/referee_checkbox-input.js"></script> <script src="/js/referee/new/referee_inline-editor.js"></script> <script type="text/javascript">
    $(function(){
        var gaCat = "F1000Research";
        if (gaCat === "") {
            gaCat = $("body").hasClass("wellcome-brand") ? "Wellcome Open Research" : "F1000Research";
        }
        GAHelper.track({category: gaCat, action: "Article Page: Recent advances in the management of lymphangioleiomyomatosis", label: "pageviews"});
        GAHelper.track({category: gaCat, action: "Article Type: Review", label: "Article Page"});
        $(".f1r-article-desk .collection-image").each(function (idx, el) {
            var whatChannel = $(el).find("a").attr("href"),
                channelName = $.trim($(el).parent().find(".collection-detail a").text()),
                gaRef = "(ID: " + whatChannel.replace("/collections/", "") + ") " + channelName;
            GAHelper.track({category: 'ChannelStats', action: "Article Page: Recent advances in the management of lymphangioleiomyomatosis", label: gaRef});
        });
    });
</script> <script>
    $(function(){R.ui.buttonDropdowns('.dropdown-for-downloads');});
    $(function(){R.ui.toolbarDropdowns('.toolbar-dropdown-for-downloads');});
</script> <script src="/js/article/track_article.js" type="text/javascript"></script> <script type="text/javascript">
    $.get("/articles/acj/14564/15851")
</script> <script type="text/javascript" src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js"></script> <script type="text/javascript" src="/js/app/messenger.js"></script> <script type="text/javascript" src="/js/article/article_mobiles.js"></script> <script src="/js/vendor/clipboard.min.js"></script> <script src="/js/shared_scripts/modal-dialogue.js"></script> <script src="/js/shared_scripts/clipboard.js"></script> <script src="/js/article/thesaurus-terms-display.js"></script> <script>
    new F1000.Clipboard();
    new F1000.ThesaurusTermsDisplay("faculty-reviews", "article", "15851");
</script> <script>
    $(document).ready(function() {
        $( "#frame1" ).on('load', function() {
            var mydiv = $(this).contents().find("div");
            var h     = mydiv.height();
            console.log(h)
        });

        
        var tooltipLivingFigure = jQuery(".interactive-living-figure-label .icon-more-info"),
            titleLivingFigure = tooltipLivingFigure.attr("title");
        tooltipLivingFigure.simpletip({
            fixed: true,
            position: ["-115", "30"],
            baseClass: 'small-tooltip',
            content:titleLivingFigure + "<div class='tooltip-arrow'></div>"
        });
        tooltipLivingFigure.removeAttr("title");

        $("body").on("click", ".cite-living-figure", function(e) {
            e.preventDefault();
            var ref = $(this).attr("data-ref");
            $(this).closest(".living-figure-list-container").find("#" + ref).fadeIn(200);
        });
        $("body").on("click", ".close-cite-living-figure", function(e) {
            e.preventDefault();
            $(this).closest(".popup-window-wrapper").fadeOut(200);
        });

                $(document).on("mouseup", function(e) {
            var metricsContainer = $(".article-metrics-popover-wrapper");
            if (!metricsContainer.is(e.target) && metricsContainer.has(e.target).length === 0) {
                $(".article-metrics-close-button").click();
            }
        });

        var articleId = $('#articleId').val();

        if($("#main-article-count-box").attachArticleMetrics) {
            $("#main-article-count-box").attachArticleMetrics(articleId, {
                articleMetricsView: true
            });
        }
    });

    var figshareWidget = $(".new_figshare_widget");
    if (figshareWidget.length > 0) {
        window.figshare.load("f1000", function(Widget) {
            // Select a tag/tags defined in your page. In this tag we will place the widget.
            _.map(figshareWidget, function(el){
                var widget = new Widget({
                    articleId: $(el).attr("figshare_articleId")
                    //height:300 // this is the height of the viewer part. [Default: 550]
                });
                widget.initialize(); // initialize the widget
                widget.mount(el); // mount it in a tag that's on your page
                // this will save the widget on the global scope for later use from
                // your JS scripts. This line is optional.
                //window.widget = widget;
            });
        });
    }
</script>

<script>
    $(document).ready(function () {

        
        var reportIds = {
                           "34947": 0,
                           "34948": 0,
                           "34949": 0,
                           "34950": 0,
                    };

        $(".referee-response-container,.js-referee-report").each(function(index, el) {
            var reportId = $(el).attr("data-reportid"),
                reportCount = reportIds[reportId] || 0;
            $(el).find(".comments-count-container,.js-referee-report-views").html(reportCount);
        });

        var uuidInput = $("#article_uuid"),
            oldUUId = uuidInput.val(),
            newUUId = "fff270c8-a4bb-4b8a-ae4c-8d7551813e17";
        uuidInput.val(newUUId);

        $("a[href*='article_uuid=']").each(function(index, el) {
            var newHref = $(el).attr("href").replace(oldUUId, newUUId);
            $(el).attr("href", newHref);
        });

    });
</script>              </div>
        </div>

        
            
            <div class="o-page__footer sticky-email-wrapper">
                
                

                


<footer class="c-footer t-inverted">

    <div class="o-wrapper">
        <div class="o-layout">


                        
            <div class="o-layout__item u-mb--3">
                <div class="c-branding c-branding--research">
                    <img src="/img/research/F1000Research_white.svg" alt="F1000Research">
                </div>
            </div>


                        
            <div class="o-layout__item u-1/3@md u-mb--3">

                <span class="c-hr c-hr--thick c-hr--low u-mb--2"></span>

                <p class="t-h3 u-mt--0 u-mb--0">An innovative open access publishing platform offering rapid publication and open peer review, whilst supporting data deposition and sharing.</p>

            </div>


                        
            <div class="o-layout__item u-2/3@md">

                <span class="c-hr c-hr--thick c-hr--low u-mb--2"></span>

                <div class="o-layout">
                    <nav class="c-footer__nav">

                            <div class="o-layout__item u-3/5@sm u-mb--3">


                                <div class="o-columns o-columns--2">

                                                                            <a href="/browse/articles" class="t-body c-footer__nav-item "      >Browse</a>
                                                                            <a href="/gateways" class="t-body c-footer__nav-item "      >Gateways</a>
                                                                            <a href="/collections" class="t-body c-footer__nav-item "      >Collections</a>
                                                                            <a href="/about" class="t-body c-footer__nav-item "      >How it Works</a>
                                                                            <a href="https://blog.f1000.com/blogs/f1000research/" class="t-body c-footer__nav-item "      >Blog</a>
                                                                            <a href="/contact" class="t-body c-footer__nav-item "      >Contact</a>
                                                                            <a href="/developers" class="t-body c-footer__nav-item u-hide u-show@navbar"      >For Developers</a>
                                                                            <a href="/published/rss" class="t-body c-footer__nav-item "   title="RSS feed of published articles"     >RSS</a>
                                    
                                </div>

                            </div>

                            <div class="o-layout__item u-2/5@sm u-center u-right@sm u-mb--3">

                                <div class="u-hide u-show@lg">
                                    <div class="_mdl-layout">
                                        <a class="mdl-button mdl-js-button mdl-button--inverted mdl-button--no-shadow mdl-js-ripple-effect mdl-button--outline" href="/for-authors/publish-your-research"   data-test-id="footer_submit_research"  >Submit Your Research</a>
                                    </div>
                                </div>

                            </div>

                    </nav>
                </div>

            </div>

            <div class="o-layout__item u-mb--2">
                <div class="c-footer__share">
                        <div class="c-footer__share">
        <span class="c-footer__share-icon" title="Open Access">
            <span class="f1r-icon icon-100_open_access license-icon"></span>
        </span>

        <a class="c-footer__share-icon" href="//creativecommons.org/licenses" target="_blank" title="Creative Commons License CC-BY">
            <span class="f1r-icon icon-116_cc license-icon license-icon-cc"></span>
            <span class="f1r-icon icon-117_ccby license-icon license-icon-cc"></span>
        </a>

        <a class="c-footer__share-icon" href="//creativecommons.org/about/cc0" target="_blank" title="Creative Commons License CC0">
            <span class="f1r-icon icon-118_cco license-icon"></span>
        </a>

    </div>
                </div>
            </div>


                        
            <div class="o-layout__item u-1/3@md u-mb--3">

                <span class="c-hr c-hr--low u-mb--3"></span>

                <p class="c-footer__social u-mt--0 u-mb--0 u-white--low-med">Follow us
                    <a href="https://www.facebook.com/F1000" target="_blank" class="c-footer__social-icon f1r-icon icon-55_footer_facebook"></a>
                    <a href="https://twitter.com/#!/F1000Research" target="_blank" class="c-footer__social-icon f1r-icon icon-56_footer_twitter"></a>
                    <a href="http://www.youtube.com/user/F1000research" target="_blank" class="c-footer__social-icon f1r-icon icon-57_footer_youtube"></a></p>

            </div>


                        
            <div class="o-layout__item u-2/3@md u-right@md">

                <span class="c-hr c-hr--low u-mb--3"></span>

                <p class="t-caption u-white--low-med">&copy; 2012-2020 F1000 Research Ltd. ISSN 2046-1402 | <a href="/about/legal" class="copyrightLegal">Legal</a> | Partner of <a target="_blank" href="http://www.who.int/hinari/en/">HINARI</a>  &bull; <a target="_blank" href="http://crossref.org/">CrossRef</a> &bull; <a target="_blank" href="http://about.orcid.org/">ORCID</a> &bull; <a target="_blank" href="http://www.fairsharing.org">FAIRSharing</a></p>

            </div>
        </div>
    </div>

</footer>            </div>
        
    </div>

            <div class="js-cookie-spacer"></div>
        <div class="cookie-warning">
            <div class="instruction">The F1000Research website uses cookies. By continuing to browse the site, you are agreeing to our use of cookies. <a class="js-scroll-to" href="/about/legal/privacypolicy#use-of-cookies" data-scroll-target="#use-of-cookies">Find out more &raquo;</a></div>
            <div class="close-button"></div>
        </div>
    
    <script>
                    R.templateTests.simpleTemplate = R.template('<p class="$variable.one">$text</p><p class="${variable.two}">$text</p><p class="$!variable.three">$text</p><p class="$!{variable.four}">$text</p><p class="${selector}.five">$text</p>');
            R.templateTests.runTests();
        
        var F1000platform = new F1000.Platform({
            name: "f1000research",
            displayName: "F1000Research",
            hostName: "f1000research.com",
            id: "1",
            editorialEmail: "research@f1000.com",
            infoEmail: "info@f1000.com",
            usePmcStats: true
        });

                    $(function(){R.ui.dropdowns('.dropdown-for-authors, .dropdown-for-about, .dropdown-for-myresearch');});
            // $(function(){R.ui.dropdowns('.dropdown-for-referees');});

            $(document).ready(function () {
                if ($(".cookie-warning").is(":visible")) {
                    $(".sticky").css("margin-bottom", "35px");
                    $(".devices").addClass("devices-and-cookie-warning");
                }
                $(".cookie-warning .close-button").click(function (e) {
                    $(".devices").removeClass("devices-and-cookie-warning");
                    $(".sticky").css("margin-bottom", "0");
                });

                $("#tweeter-feed .tweet-message").each(function (i, message) {
                    var self = $(message);
                    self.html(linkify(self.html()));
                });

                $(".partner").on("mouseenter mouseleave", function() {
                    $(this).find(".gray-scale, .colour").toggleClass("is-hidden");
                });
            });
        
    </script>

            
<div class="sign-in-popup">
	<!-- <a href="#" class="sign-in shadow">Sign in <span class="sign-in-image-active"></span></a> -->
	<a href="#" class="sign-in ${locale}">Sign In <span class="arrow-closed sign-in-arrow-padding arrow-opened"></span></a>
	<div class="sign-in-form">

            <form action="https://f1000research.com/j_spring_oauth_security_check" id="googleOAuth" method="post"  target="_top" >
                                    <input class="target-field" type="hidden" name="target" value="/articles/7-758.html"/>
                            <input id="google-remember-me" name="_spring_security_oauth_remember_me" type="hidden" value="true"/>
        <input id="system-google" name="system" type="hidden" value="GOOGLE"/>
    </form>
            <form action="https://f1000research.com/j_spring_oauth_security_check" id="facebookOAuth" method="post"  target="_top" >
                                    <input class="target-field" type="hidden" name="target" value="/articles/7-758.html"/>
                            <input id="facebook-remember-me" name="_spring_security_oauth_remember_me" type="hidden" value="true"/>
        <input id="system-fb" name="system" type="hidden" value="FACEBOOK"/>
    </form>
            <form action="https://f1000research.com/j_spring_oauth_security_check" id="orcidOAuth" method="post"  target="_top" >
                                    <input class="target-field" type="hidden" name="target" value="/articles/7-758.html"/>
                            <input id="orcid-remember-me" name="_spring_security_oauth_remember_me" type="hidden" value="true"/>
        <input id="system-orcid" name="system" type="hidden" value="ORCID"/>
    </form>
		<form id="sign-in-form" class="login-container" action="https://f1000research.com/login" method="post" name="f">
           <div id="sign-in-form-gfb-popup"></div>

                                                            <input class="target-field" type="hidden" name="target" value="/articles/7-758.html"/>
                            			<input type="text" name="username" id="signin-email-box" class="sign-in-input" placeholder="Email address" autocomplete="email">
			<input type="password" name="password" id="signin-password-box" class="sign-in-input" placeholder="Password" autocomplete="current-password">
			<div class="sign-in-remember">
                <div class="checkbox-wrapper">
    				<input type="checkbox" id="remember-me" name="remember_me" class="checkbox is-hidden">
                </div>
                <span class="checkbox-label">Remember me</span>
			</div>
			<a href="#" class="sign-in-link" id="forgot-password-link">Forgotten your password?</a>
			<div class="sign-in-button-container margin-top margin-left-20 margin-bottom">
				<button type="submit" id="sign-in-button" class="sign-in-buttons general-white-orange-button">Sign In</button>
				<button type="button" id="sign-in-cancel" class="sign-in-buttons sign-in-cancel-button margin-left">Cancel</button>
				<div class="clearfix"></div>
			</div>
			<div class="sign-in-error">Email or password not correct. Please try again</div>
			<div class="sign-in-loading">Please wait...</div>
		</form>
		<div class="forgot-password-container">
			
<script type="text/javascript">
	$(function(){
		// Note: All the setup needs to run against a name attribute and *not* the id due the clonish
		// nature of facebox...
		$("a[id=googleSignInButton]").click(function(event){
            event.preventDefault();
            $("input[id=oAuthSystem]").val("GOOGLE");
            $("form[id=oAuthForm]").submit();
        });
        $("a[id=facebookSignInButton]").click(function(event){
            event.preventDefault();
            $("input[id=oAuthSystem]").val("FACEBOOK");
            $("form[id=oAuthForm]").submit();
        });
        $("a[id=orcidSignInButton]").click(function(event){
            event.preventDefault();
            $("input[id=oAuthSystem]").val("ORCID");
            $("form[id=oAuthForm]").submit();
        });
	});
</script>

<span class="text first">
	If you've forgotten your password, please enter your email address below and we'll send you instructions on how to reset your password.
    <p>The email address should be the one you originally registered with F1000.</p>
</span>
<input name="email" class="sign-in-input" id="email-forgot-password" type="text" placeholder="Email address">
<div class="forgot-password-email-error">
	Email address not valid, please try again
</div>
<div class="forgot-password-google-email-error">
    <p>You registered with F1000 via Google, so we cannot reset your password.</p>
	<p>To sign in, please click <a href="#" id="googleSignInButton">here</a>.</p>
    <p>If you still need help with your Google account password, please click <a href="https://www.google.com/accounts/recovery">here</a>.</p>
</div>
<div class="forgot-password-facebook-email-error">
    <p>You registered with F1000 via Facebook, so we cannot reset your password.</p>
    <p>To sign in, please click <a href="#" id="facebookSignInButton">here</a>.</p>
	<p>If you still need help with your Facebook account password, please click <a href="https://www.facebook.com/recover/initiate">here</a>.</p>
</div>
<div class="clearfix"></div>
<div class="forgot-password-captcha-error">
	Code not correct, please try again
</div>
<div class="clearfix"></div>
<div class="sign-in-button-container margin-left-20 margin-bottom">
	<button type="button" id="sign-in-reset-password" class="sign-in-buttons general-white-orange-button">Reset password</button>
	<button type="button" id="forgot-password-cancel" class="sign-in-buttons sign-in-cancel-button margin-left">Cancel</button>
	<div class="clearfix"></div>
</div>
<span class="text last">
	<a href="mailto:">Email us</a> for further assistance.
</span>
<form action="https://f1000research.com/j_spring_oauth_security_check" id="oAuthForm" method="post" target="_top">
                        <input class="target-field" type="hidden" name="target" value="/articles/7-758.html"/>
                <input id="oAuthSystem" name="system" type="hidden"/>
</form>
			<div class="forgot-password-server-error">Server error, please try again.</div>
			<div class="sign-in-success">
                <p>We have sent an email to <span id="email-value"></span>, please follow the instructions to reset your password.</p>
                <p>If you don't receive this email, please check your spam filters and/or contact .</p>
            </div>
			<div class="sign-in-loading">Please wait...</div>
		</div>

		<div class="sign-in-form-register-section">
			<div class="sign-in-button-container margin-left-20 margin-bottom">
				<a href="/register" title="Register"><button type="button" id="sign-in-register-button" class="sign-in-buttons general-white-orange-button">Register</button></a>
				<div class="clearfix"></div>
			</div>
		</div>

	</div>
</div>

<script type="text/javascript">
$(document).ready(function () {

    signIn.createSignInAsRow($("#sign-in-form-gfb-popup"));

    $(".target-field").each(function () {
        var uris = $(this).val().split("/");
        if (uris.pop() === "login") {
        	$(this).val(uris.toString().replace(",","/"));
        }
    });
});
</script>
        <div id="templateOverlay" class="is-hidden" hidden="hidden">
  <div class="o-overlay js-overlay is-hidden" hidden="hidden"></div>
</div>

<div id="templateExternalMessages" class="is-hidden" hidden="hidden">
  <div class="o-modal o-modal--auto@md js-external-messages is-hidden" hidden="hidden">
    <div class="o-modal__body">
      <section class="c-console">
        <div class="_mdl-layout c-console__bdy js-external-messages-body"></div>
        <footer class="_mdl-layout c-console__ftr o-flex o-flex--reverse js-external-messages-footer">
          <button type="button" class="mdl-button mdl-js-button mdl-button--raised mdl-button--colored c-console__btn js-external-messages-close" data-action="maintenance-close">I Understand</button>
        </footer>
      </section>
    </div>
  </div>
</div>

<script src="https://cdnjs.cloudflare.com/ajax/libs/moment.js/2.22.1/moment.min.js"></script>

<script src="/js/namespace.js"></script>
<script src="/js/constants.js"></script>
<script src="/js/utilities.js"></script>

<script>
                  F1000.ExtenalMaintenanceItems = [
    {
      start: '2018-12-10T14:21:00Z',
      end: '2018-12-13T16:00:00Z',
      msg: 'This site will be down for a short time on XX December. It is advisable not to start any submissions on that day or you may lose your work unless you save regularly.',
      cookieName: 'outage23122018',
      editor: false,
    }
  ];
</script>

<script src="/js/shared_scripts/cookie-helper.js"></script>
<script src="/js/shared_scripts/mdl-helper.js"></script>

<script src="/js/app/external-maintenance.js"></script>

                <script type="text/javascript">
            (function(i,s,o,g,r,a,m){i['GoogleAnalyticsObject']=r;i[r]=i[r]||function(){
            (i[r].q=i[r].q||[]).push(arguments)},i[r].l=1*new Date();a=s.createElement(o),
            m=s.getElementsByTagName(o)[0];a.async=1;a.src=g;m.parentNode.insertBefore(a,m)
            })(window,document,'script','//www.google-analytics.com/analytics.js','ga');

            ga('create', 'UA-5646075-11', 'auto');
            ga('require', 'displayfeatures');
            ga('send', 'pageview');
        </script>
        
                <script type="text/javascript" src="/js/app/research.analytics.js"></script>

        <!-- Start of HubSpot Embed Code -->
        <script type="text/javascript" id="hs-script-loader" async defer src="//js.hs-scripts.com/4475190.js"></script>
        <!-- End of HubSpot Embed Code -->
    
            <script src="https://my.hellobar.com/4e0495c6f18cbd68731a1dc1978195a144e767ba.js" type="text/javascript" charset="utf-8" async="async"></script>
    </body>

</html>